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ABSTRACT 
This thesis describes research pursued in two areas, both involving the 
design and synthesis of sequence specific DNA-cleaving proteins. The first 
involves the use of sequence-specific DNA-cleaving metalloproteins to probe 
the structure of a protein-DNA complex, and the second seeks to develop 
cleaving moieties capable of DNA cleavage through the generation of a non-
diffusible oxidant under physiological conditions. 
Chapter One provides a brief review of the literature concerning 
sequence-specific DNA-binding proteins. Chapter Two summarizes the 
results of affinity cleaving experiments using leucine zipper-basic region 
(bZip) DNA-binding proteins. Specifically, the NH2-terminal locations of a 
dimer containing the DNA binding domain of the yeast transcriptional 
activator GCN4 were mapped on the binding sites 5'-CTGACTAAT-3' and 5'-
ATGACTCTT-3' using affinity cleaving. Analysis of the DNA cleavage 
patterns from Fe•EDTA-GCN4(222-281) and (226-281) dimers reveals that the 
NH2-termini are in the major groove nine to ten base pairs apart and 
symmetrically displaced four to five base pairs from the central C of the 
recognition site. These data are consistent with structural models put 
forward for this class of DNA binding proteins. The results of these 
experiments are evaluated in light of the recently published crystal structure 
for the GCN4-DNA complex. Preliminary investigations of affinity cleaving 
proteins based on the DNA-binding domains of the bZip proteins Jun and Fos 
are also described. 
Chapter Three describes experiments demonstrating the simultaneous 
binding of GCN4(226-281) and 1-Methylimidazole-2-carboxamide-netropsin 
(2-ImN), a designed synthetic peptide which binds in the minor groove of 
DNA at 5'-TGACT-3' sites as an antiparallel, side-by-side dimer. Through the 
vii 
use of Fe•EDTA-GCN4(226-281) as a sequence-specific footprinting agent, it is 
shown that the dimeric protein GCN4(226-281) and the dimeric peptide 2-
ImN can simultaneously occupy their common binding site in the major and 
minor grooves of DNA, respectively. The association constants for 2-ImN in 
the presence and in the absence of Fe•EDTA-GCN4(226-281) are found to be 
similar, suggesting that the binding of the two dimers is not cooperative. 
Chapter Four describes the synthesis and characterization of PBA-J3-0H-
His-Hin(139-190), a hybrid protein containing the DNA-binding domain of 
Hin recombinase and the putative iron-binding and oxygen-activating 
domain of the antitumor antibiotic bleomycin. This 54-residue protein, 
comprising residues -139-190 of Hin recombinase with the dipeptide 
pyrimidoblamic acid-J3-hydroxy-L-histidine (PBA-J3-0H-His) at the NH2 
terminus, was synthesized by solid phase methods. PBA-J3-0H-His-Hin(139-
190) binds specifically to DNA at four distinct Hin binding sites with affinities 
comparable to those of the unmodified Hin(139-190). In the presence of 
dithiothreitol (DTT), Fe•PBA-J3-0H-His-Hin(139-190) cleaves DNA with 
specificity remarkably similar to that of Fe•EDTA-Hin(139-190), although 
with lower efficiency. Analysis of the cleavage pattern suggests that DNA 
cleavage is mediated through a diffusible species, in contrast with cleavage by 
bleomycin, which occurs through a non-diffusible oxidant. 
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Many key cellular functions, including DNA replication, transcription of 
active genes, and DNA repair are performed by DNA-binding proteins. 
Regulation of these functions is crucial to the proper control of 
differentiation, response to extracellular signals, and cell growth; in many 
cases, this regulation is achieved by sequence-specific DNA-binding proteins. 
Often, relatively small, discrete domains are sufficient for sequence-specific 
DNA recognition, allowing for extensive biochemical, genetic, and structural 
studies of these DNA-binding domains. Although the principles by which 
proteins bind to specific sequences of DNA remain incompletely understood, 
such studies have indicated that many DNA-binding proteins can be grouped 
into classes that use related structures for recognition.J,2 A great deal of 
progress has been made in our understanding of protein-DNA interactions 
since the first three-dimensional structures of sequence-specific DNA-binding 
proteins were reported over a decade ago.3-5 Much of our improved 
understanding results from X-ray crystallographic and multidimensional 
NMR studies of these proteins in complex with their DNA binding sites. The 
first cocrystal structure was reported in 1986;6 at present, more than twenty 
such structures, representing members of most known classes of DNA-
binding proteins, have been solved. Excellent reviews of DNA-binding 
proteins have been published recently,1,2,7 and reviews of the discovery of 
DNA-binding proteins8 and early structural work in the field9 can be found 
in theses by former Dervan group members. The intent of this chapter is to 
provide a brief description of the classes of sequence-specific DNA-binding 
2 
proteins for which structural data are available, with an emphasis on 
structures reported in the last two years and their relevance to our 
understanding of the principles of protein-DNA recognition. 
HELIX-TURN-HELIX PROTEINS 
Prokaryotic Repressors. 
The helix-turn-helix (HTH) proteins were the first class of sequence-
specific DNA-binding proteins to be discovered)O,ll One subclass of HTH 
proteins consists of a group of prokaryotic repressor proteins. The three 
dimensional structures of protein-DNA complexes for seven of these 
proteins, including the repressor and cro proteins of the bacteriophages 43412-
15 and J..16-18, and the E. coli CAP protein19 and lac20and trp21repressors 
have been determined. In addition, the structure of the E. coli Fis protein in 
the absence of DNA has been solved22,23, and preliminary data have been 
reported for the protein-DNA complex of Hin recombinase from Salmonella 
typhimuruim.24 These proteins bind to their C2-symmetric DNA operator 
sites as symmetric homodimers. Each protein monomer contains an 
approximately 20 residue HTH element that forms two a-helices connected 
Figure 1. A schematic view of the A. repressor dimer bound to DNA.17 
3 
by a tight turn and crossing each other at an angle of approximately 
120°.10,11,25 The second of these helices is often described as the "recognition 
helix" due to its importance in determining sequence specficity,26 and it lies 
in the major groove of DNA (Fig. 1). 
The amino acid sequences for the HTH elements for the proteins listed 
above are shown in Figure 2. In addition to the examples listed, numerous 
proteins have been classified as HTH proteins based on sequence similarity.25 
Conserved features in the HTH sequence include a glycine at residue 9 to 
allow a sharp turn, hydrophobic residues at positions 4 and 15 that permit 
conserved packing of the helices against one another, and a small residue, 
usually glycine or alanine, and rarely a 13-branched residue, at position 5, 
which is wedged between the two helices. 25 
HELIX1 Turn HELIX2 
Position -2 1 5 10 15 20 
A CRO (14) F G Q T KTAK D L G V Y Q s A :I N K A I H ( 35) 
434 CRO ( 16) M T Q T E LA T K A G V K Q Q S :I Q L I E A (37) 
A REP (31) L s Q E s VA D K MGM G Q s G V G A L F N (52) 
434 REP (16) L N Q A E LA Q K V G T T Q Q s :r E Q L E N (37) 
LAC REP ( 4) v T L y DVA E y AGV s y Q TV s R v v N (25) 
CAP (167) I T R Q E :r G Q I V G C s R E T V G R I L K (188) 
TRP REP ( 66) M s Q R E L Jt N E L G A G I A T :r T R G s N (93) 
FIS (72) G N Q TRAA L M M G I N R G T L R K K L K (93) 
HIN ( 158) H p R Q Q LA I I F G I G v s T L y R y F p ( 179) 
Figure 2. Sequences of a number of HTH proteins. Sequences can be found in 
references 9, 22, 23, and 25. 
As an example of sequence-specific recognition of DNA by HTH proteins, 
the complex of A. repressor with its DNA operator is illustrated in Figure 3.17 
Importantly, residues both inside and outside the conserved HTH motif make 
crucial contacts to the DNA bases and backbone. The NH2 termini of both 
HTH helices are in a position to allow their helix dipoles to interact favorably 
with the phosphate backbone. Se quence-specific contacts are m ade 
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exclusively in the major groove, which allows greater discrimination 
between base pairs than the minor groove.27 The NH2 terminus of the 
second HTH helix (helix 3) projects into the major groove allowing sequence 
specific hydrogen-bond contacts to the DNA bases to be made by Gln-44 and 
Ser-45.17 Additional sequence-specific contacts are made by Asn-55, located in 
the loop after helix 3, and Lys 4 in the NH2-terminal arm, a region required 
for efficient DNA binding (Fig. 3A).28,29 (A higher resolution structure 
demonstrates that Lys-3 also makes a specific contact through its main-chain 
carbonyl group).l8 Hydrophobic contacts involving Ala-49, lle-54, Gly-46, and 
Ser-45 are also made with thymine CS-methyl groups in base pairs 3 and 5.17 
Nonspecific contacts with the phosphodiester backbone are also made by 
residues within and without the HTH unit (Fig. 3B); these contacts are 






Figure 3. Schematic views of the interaction of a A. repressor monomer with 
its half site showing specific (A) and nonspecific contacts (B).17 
As is seen in other HTH proteins, some contacts, such as the hydrogen-
bonding of the Gln-44 side chain amido group with N6 and N7 of adenine, 
had been anticipated as those likely to discriminate among base pairs. 27 In 
5 
other cases, such as the hydrogen bond between the side chain hydroxyl group 
of Ser-45 and the N7 of guanine, contacts were unanticipated and, acting 
alone, would not discriminate between base pairs. Another indication of the 
highly cooperative nature of specific interactions is that more than one side 
chain may be required to recognize a specific base pair; for example, the 
conformation of Gln-44 is stabilized by Gln-33, which also makes a contact 
with the phosphate backbone (Fig. 4). This arrangement of the Gin residues at 
theN-termini of both helices is also observed in the 434 repressor structure.15 
In spite of this conserved arrangement, the first two residues of the 
recognition helix in 434 repressor interact with adjacent base pairs, while the 
equivalent residues in A. repressor contact bases separated by one base pair, 
highlighting the difficulty of predicting the sequence specificity of closely 
related proteins.l5,17 Furthermore, interaction of multiple base pairs with 
one amino acid residue, as is seen with Ser-45 in the A. repressor structure, is 
also observed in many protein-DNA complexes.2,11 
A. 
o~A 
I N N~ 
,o-lf=O (, ~~ o T 
,•' 0- N :;;.o' •.H )l R 
H / 'N N' 
H • , N .. N H H" 'H y >= . , . h '> 0·---H-N,o·' '0 CH, 
GLN33 ) 
GLN44 
Figure 4. Sketches demonstrating multiple side-chain interactions in the 
major groove of (A) base pair 2 and (B) base pair 6 of the A. repressor operator 
half-site. Modified from reference 17. 
The use of elements outside the HTH region for stabilizing contacts, such 
as those made by the NH2-terminal arm of A. repressor, 29 is also seen in other 
6 
HTH proteins. The C02H-terminal domain of A cro is critical for high affinity 
DNA binding.30 In addition, the NH2-terminal arm of the 434 repressor 
makes important contacts in the minor groove that are proposed to 
contribute to the sequence specificty of the protein.lS Similary, the NH2-
terminal region of the Hin DNA-binding domain interacts with the minor 
groove in a manner that contributes significantly to its affinity and 
specificity. 8,31-34 
a 
Figure 5. HTH-containing domains from a variety of proteins.11 All HTHs 
are shown in the same orientation; the HTH helices and turn are labeled in 
part A. (A) 434 repessor DNA-binding domain. (B) Cro. (C) A repressor DNA-
binding domain. (D) A Cro. (E) CAP DNA-binding domain. (F) Trp repressor. 
It is important to note that the HTH element is not a stably folded 
domain; rather, it is a substructure that occurs in a variety of otherwise 
different, cooperatively folded domains (Fig. 5).11 Although the three-
dimensional structure of the HTH element is highly conserved across the 
known HTH proteins, the angle at which the second helix of the HTH 
interacts with the major groove varies significantly across this subclass in a 
7 
manner that depends on the structure of the rest of the domain.11 For 
instance, the 434 proteins and A repressor bind similarly, with their 
recognition helices approximately parallel to the major groove, pointing 
toward the center of the dimeric binding site.11 In contrast, the recognition 
helix of CAP lies parallel to the bases 19 and the recognition helix of the lac 
repressor lies in the opposite orientation, projecting away from the center of 
the dim eric binding site. 20 
Another difference in the structures of HTH protein-DNA complexes is in 
the extent of DNA bending observed. The structure of the DNA in these 
complexes varies from the near canonical B-form seen in the A repressor 
structure17 to the 90° bend observed with CAP.19 In the latter case, the severe 
bending, imposed largely by two 40° kinks allows the protein to contact 27 out 
of the 30 base pairs in its recognition site, rather than the 20 base pairs that 
could be contacted in the absence of bending.19 The DNA bending in the CAP 
complex also contributes to the protein's sequence specificity. For example, 
both kinks occur at highly conserved 5'-TG-'3' steps thought to be more easily 
kinked than other sequence combination.19 In addition, an A-T rich narrow 
minor groove in the confers sequence specificity on both the CAP complex 
and the 434 repressor complex_l5,19 
Sequence-dependent conformational flexibility of the DNA, or "indirect 
readout," has been proposed to account almost exclusively for the specific 
binding of the trp repressor to its operator site.21 Remarkably, no direct 
hydrogen bonds or nonpolar contacts are seen between the protein and the 
DNA base pairs.21 However, the DNA deformations observed are not far 
from B-form and are much less extensive than those discussed above, leading 
some investigators to suggest that the complex contains an incorrect binding 
site and is thus an example of non-specific DNA binding.35 Later studies 
8 
have shown that the operator site used is in fact a high affinity site for trp 
repressor;36,37 however, it appears that the DNA interaction is altered under 
the conditions of crystallization, resulting in a nonspecific complex.25,37 
Resolution of this controversy awaits further structural characterization of 
trp-operator complexes. 
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Figure 6. Sequences of the homeodomains of Antennepedia, MATa.2, and 
engrailed. The sequence of the HTH from A.-repressor is shown for 
comparison. Underlined regions correspond to helices. Sequences are from 
references 8, 25, 42. 
Homeodomain Proteins. 
A number of eukaryotic transcriptional regulatory proteins contain a 60 
amino acid sequence known as the homeodomain.38 The structure of the 
Drosophila antennepedia protein and its complex with DNA have been 
determined by NMR,39,40 and cocrystal structures of the Drosophila engrailed 
protein and the yeast repressor MAT a.2 have been solved.41,42 These 
structures have confirmed predictions based on weak sequence similarity that 
these proteins contained a HTH motif (Fig. 6).43,44 Unlike the prokaryotic 
repressor HTH proteins, the homeodomain is a stably folded structure, and 
homeodomain proteins bind to their recognition sites as monomers.1 The 
structure of the engrailed homeodomain is very similar to that of the other 
two homeodomains, consisting of an extended NH2-terminal arm and three 
a.-helices (Fig. 7 A). 41 Helices 1 and 2 pack against each other in an 
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antiparallel arrangement, spanning the major groove approximately 
perpendicular to the DNA backbone.41 Helix 3 is located in the major groove, 
perpendicular to helices 1 and 2, and makes numerous contacts with the 
DNA (Fig. 7).41 The second HTH helix is markedly longer in homeodomain 
proteins than in the prokaryotic repressors; in the antennepedia structure, 
this long helix is kinked and has been described as two separate helices.39 
Sequence specfic contacts are made in both the major and minor grooves, the 
latter by the NH2-terminal arm (Fig. 7).41 Although the structure of the HTH 
element (helices 2 and 3) of the engrailed homeodomain superimposes well 
with the HTH from A repressor, its position in relation to the DNA is 
markedly different. Specifically, the DNA is shifted toward the C02H 
terminus of the second HTH helix and rotated slightly away from the NH2-
terminus of the first HTH helix in comparison to the A operator.41 
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Figure 7. Schematic views of (left) the engrailed homeodomain-DNA 
complex and (right) the contacts made by engrailed in the major and minor 
grooves of DNA.41 
Although MAT a2 is only 27% homologous to engrailed over its 
homeodomain (Fig. 6), the structure of its complex with its DNA binding site 
is remarkably similar to that of engrailed (compare Fig. 7 with Fig. 8).42 Both 
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proteins bind to B form DNA with few distortions.41,42 Six phosphate 
contacts and one base contact are conserved between the two protein 
complexes; these contacts appear to position the homeodomains properly 
with respect to the DNA binding sites.42 Because the residues involved in 
these contacts are conserved in all homeodomain proteins, it is likely that, 
unlike prokaryotic repressors, all homeodomain proteins will be positioned 
similarly with respect to DNA.42 The remaining base contacts are not 
conserved between the two complexes, allowing them to bind their different 
binding sites specifically, with base contacts including those predicted by 
genetic studies.45 Finally, the NH2-terminal arms of all three homeodomain 
proteins lie in the minor groove in similar conformations.40-42 
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Figure 8. Schematic views of (left) the MATa2 homeodomain-DNA complex 
and (right) the contacts made by MATa2 in the major and minor grooves of 
DNA.42 
Other Eukaryotic HTH Variants. 
Several eukaryotic DNA-binding proteins unrelated to the homeodomain 
proteins have been characterized structurally and shown to contain elements 
similar to the HTH. Among these, a cocrystal structure has been reported for 
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only one protein-DNA complex, that of the HNF-3y DNA-binding domain 
complexed to its recognition site.46 The NH2-terminal half of this domain 
forms a three-helix structure that places the third helix in the major groove of 
DNA.46 Regions of 13-sheet and extended structure also interact with the 
DNA in the minor groove.46 Overall, the structure of the DNA-binding 
domain bears a marked resemblance to that of the globular domain of histone 
5, which may interact with DNA in a similar fashion.47 Another interesting 
feature of the HNF-DNA complex is a network of four well ordered water 
molecules, some of which mediate sequence specific hydrogen bonds between 
amino acid side chains and the DNA bases.46 
Solution structures have also been reported for the protooncogene Myb48 
and for the POD-specific domain of the transcription factor Oct-1.49,50 The 
POU domain structure resembles the DNA-binding domains of the A. and 434 
repressors, with an extended first HTH helix and linker.49,50 Similarly, 
helices 2 and 3 of Myb form a helix-turn-helix structure differing from the 
prototypical HTH in the length and makeup of its turn and in the relative 
orientation of the two helices.48 Should these proteins recognize their 
binding sites as predicted, they will comprise new classes of eukaryotic HTH 
proteins. 
ZINC BINDING PROTEINS 
TFIIIA-like Zinc Finger Proteins. 
A number of otherwise unrelated proteins contain conserved cysteine 
and/or histidine residues and require zinc for proper folding and for the 
recognition of DNA.Sl,52 The first class of zinc-containing DNA-binding 
proteins to be described were identified through sequence similarities to a 
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repeated motif in TFIIIA.53 The consensus sequence of this repeat is (Phe, 
Tyr)-X-Cys-Xz or 4-Cys-X3-Phe-Xs-Leu-Xz-His-X3-His-Xs, where X is any amino 
acid, and most zinc finger proteins contain between two and nine repeats of 
this sequence.54 Based on similarities with metalloproteins of known 
structure, a model was proposed for the structure of these zinc fingers.54,55 
In this model, a two-stranded antiparallelj3-sheet, connected by a loop after 
the first conserved Cys residue, is followed by an a-helix beginning between 
the cysteine and histidine residues (Fig. 9).54,55 The packing of the hairpin 
and helix was proposed to be stablized by conserved hydrophobic interactions 
and by tetrahedral coordination of the zn2+ ion by the conserved cysteine and 
histidine residues.54,55 Solution structures of fingers from various zinc 
finger proteins have been determined, and their structure is in general accord 
with the predicted structure, with stretches of 310 helix in the helical region 
and, in some cases, minor deviations from 13-haipin structure.56-60 
Figure 9. Schematic view of proposed zinc finger modet54 
The structures of two protein-DNA complexes containing zinc finger 
proteins have been determined.61,62 In the first complex, a three-finger 
fragment from Zif interacts with its DNA binding site in a very 
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straightforward manner: each finger contacts three base pairs of the nine base 
pair binding site with the amino-terminal end of its a.-helix,61 consistent 
with the model put forward by Berg.54,63 The fingers are related to one 
another by a rotation of approximately 96° (3 x 32°) and a translation of 
roughly 10 A (3 x 3.3A) along the DNA helix (Fig. 10).61 The DNA is 
essentially B-form.61 Most of the DNA contacts, including all 11 hydrogen 
bonds made to the DNA bases, are with the G-rich strand of the DNA binding 
site (Fig. 10).61 
Fln~r 3 COOO< 
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Figure 10. Schematic views of (left) the Zif-DNA complex and (right) the 
sequence-specific base contacts made by each Zif finger in the major groove of 
DNA.61 
Contacts with the bases are made by the residue immediately preceding 
the a.-helix, as well as the residues in the second, third, and sixth positions of 
the helix;61 some of these interactions had been predicted from model 
building and genetic studies.64 For fingers 1 and 3, the residues in those 
positions are Arg, Asp, Glu, and Arg, respectively; for finger 2, they are Arg. 
Asp, His, and Thr. In all cases the first Arg residue forms hydrogen bonds 
with N7 and 06 of the 3'-guanine in the recognition sequence; the 
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conformation of the Arg side chain is stabilized by the Asp residue.61 In the 
first and third fingers, the second Arg interacts in a similar fashion with the 
5'-guanine, and in the second finger, the histidine forms a hydrogen bond 
with N7 or 06 of the central guanine (Fig. 10).61 Two conserved non-specific 
contacts are made by each finger, including a phosphate hydrogen bond by the 
first histidine coordinated by zinc, thereby involving the zinc atom in a DNA 
contact.61 The other conserved phosphate contact is made by a conserved 
Argon the second l3-strand.61 The protein makes an additional three contacts 
to the phosphate backbone, one of which involves the C-rich strand and 
constitutes the only direct contact with this strand. 61 
This straightforward, modular mode of recognition led to optimism that 
zinc fingers could be designed to bind each of the 64 possible 3 base sequences, 
providing a means for the construction of proteins with any desired 
specificity.61 Although some efforts at achieving novel specificity through 
"finger swap" experiments have been successful,64-66 the recently 
determined crysal structure of the DNA-binding domain of the GLI-DNA 
complex demonstrates that interactions by TFAIII-like zinc finger proteins 
cannot necessarily be predicted from our knowledge of the Zif-DNA complex 
(Fig. 11).62 
Fingers 2-5 of the human glioblastoma DNA-binding domain fit into the 
major groove and wrap around the DNA for a helical turn, but the first finger 
does not contact the DNA.62 Fingers 2 and 3 make several contacts with the 
phosphate backbone, but only a single hydrogen bond in finger 2 contacts a 
DNA base.62 Most of the contacts to DNA bases occur in fingers 4 and 5, with 
a correlation between the positions of the residues contacting DNA bases and 
the positions of Zif residues serving a similar function.62 However, only a 
weak correlation is observed between the position of these residues in the two 
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proteins that contact the phosphodiester backbone.62 In addition, there are 
differences in the way that each finger docks against the DNA that preclude 
prediction of the GLI base contacts from the Zif contacts.62 The structure of 
the DNA is also different in the two complexes; the region of the GLI DNA in 
which base contacts occur has a structure intermediate between B- and A-
form DNA.62 Thus, it appears that, like prokaryotic HTH element, the 
TFIIIA-like zinc finger is a DNA-binding element that may be presented to 
the DNA helix in a variety of different orientations. As the amino acid 
residues contacting the DNA will depend on the docking angle of the zinc 
finger, residues in different positions will make base contacts in different 
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Figure 11. Schematic views of (left) the GLI-DNA complex and (right) the 
base and phosphate contacts made by each GLI finger with the DNA.62 
Steroid Receptors. 
The steroid receptors are a group of regulatory proteins including 
recpetors for various steroid hormones, vitamin D, retinoids, and thyroid 
16 
hormones. Each protein contains separate domains for ligand binding, 
transcriptional activation, and DNA binding.67,68 Their DNA-binding 
domains consist of approximately 70 residues and contain eight conserved 
cysteine residues, with the conserved spacing Cys-X2-Cys-X13-Cys-X2-Cys-X1s-
17-Cys-Xs-Cys-X9-Cys-X2-Cys-)4-Cys, where the last cysteine is not required for 
DNA binding and the first eight were proposed to form two zinc-binding 
modules (Fig. 12).69 Steroid receptors bind to DNA as dimers, and their 
palindromic DNA binding sites can be classified into three groups: 
glucocoriticoid, estrogen, and thyroid response elements .69 The 
glucocorticoid response elements (GREs) differ from the estrogen response 
elements (EREs) in sequence, while the EREs differ from the thryoid response 
elements (TREs) in the spacing between conserved inverted repeats (Fig. 
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Figure 12. A. Sequence of the GR DNA-binding domain indicating cysteine 
residues serving as zn2+ ligands. B. Three classes of steroid receptor binding 
sites. Adapted from reference 52. 
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cysteines (residues Gly-458, Ser-459, and Val-462 in the glucocorticoid 
receptor) have been idenified as responsible for distinguishing between the 
EREs and the GREs?0,71 Similarly, residues in the second zinc-binding 
module (residues 478-481 in the glucocorticoid receptor) discriminate between 
TREs and EREs?2 
Solution structures of the DNA-binding domains of the estrogen receptor 
(ER) and the glucocorticoid receptor (GR) have been reported, as has a 
cocrystal structure of the GR-DNA complex (Fig. 13)?3-75 In all three 
structures, the protein shows a similar globular fold, distinct from the largely 
independent folding of TFIIA-like zinc fingers. Each module contains a 
nucleated zinc coordination center followed by an amphipathic a.-helix, the 
helices extending from residues Ser-459 to Glu 469 and from residue Pro-493 
to Gly-504 in the GR?4,75 The helices pack against one another and are 
stabilized by hydrophobic interactions between conserved residues?3-75 
Overall, the structure of the GR-DNA complex is very close to that predicted 
based on the structure of the GR;14 the two modules serve different 
functions, with the first making contacts with the DNA and the second 
mediating dimerization (Fig. 13)?5 The DNA is largely B-form, and DNA 
contacts occur in the major groove. The region identified as discriminating 
between EREs and GREs makes contacts with the DNA bases; specifically, Lys-
461 makes a water-mediated hydrogen bond with guanine, Val-462 is in van 
der Waals contact with thymine, and Arg-466 makes two hydrogen bonds to a 
second guanine (Fig. 13)?5 
One interesting feature of the GR-DNA complex results from an incorrect 
spacing of the two GR half-sites relative to one another. In the high-
resolution complex, a spacing of four nucleotides, rather than the optimal 
three nucleotide gap, was used between the two conserved four base pair half 
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sites?5 However, the spacing between the two monomers of the dimeric 
complex is more absolutely fixed than anticpated, resulting in the dimer 
binding to one optimal half site and a nonspecific half site three nucleotides 
away. 7 5 This preference underscores the influence of protein-protein 
interactions between monomers in selecting a binding site and explains why 
the residues found to discriminate between EREs and TREs are located in the 
dimer interface?5 
Figure 13. Schematic views of (left) the GR-DNA complex and (right) the 
contacts made by GR with its specific DNA binding site?5 
GAL4. 
Another class of sequence-specific DNA-binding proteins requiring zinc 
are related to the yeast transcriptional activator Gal4?6 GAL4 is a 
transcriptional activator that recognizes a dyad symmetric 17-bp site as a 
dimer; the NH2-terminal 65 amino acids contain its DNA-binding and 
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dimerization activities.76,77 The DNA-binding domain contains six 
conserved cysteine residues that coordinate with two zn2+ ions to form a 
binuclear metal cluster?8,79 The structure of the DNA binding domain of 
GAL4 in complex with its DNA binding site has been determined by x-ray 
crystallographic techniques (Fig. 14),80 and the solution structures of the zinc-
binding domains have also been determined.81,82 The compact, a-helical 
zinc-binding modules at the NH2 terminus (residues 8-40) of each monomer 
lie in the major groove approximately a turn and a half of the DNA helix 
apart, making contacts to the conserved CCG triplets at the far ends of the 
palindromic binding site. 80 The zinc domain is connected by an exte~ded 
linker region (residues 41-49) to short coiled-coil dimerization domain 
(residues 50-64);80 this domain is monomeric and these regions are 
conformationally labile in the absence of DNA.81 The DNA exhibits no 
significant deviations from B-form DNA.80 
Figure 14. Schematic views of (left) the GAL4-DNA complex and (right) the 
contacts made by a GAL4 monomer with its half site?,80 
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The coiled-coil region approaches the center of the DNA binding site in 
the minor groove, perpendicular to the double helical axis. 80 Its helical 
dipoles are directed toward the phophate backbone, and phosphate contacts 
are also made by the main-chain and side-chain NH groups of Arg-51.80 
Although the linker is less well ordered than other segments of the protein, 
several nonspecific contacts are made by positively charged side chains in this 
region. 80 Amino acid residues in the zinc-binding domain make base 
contacts with all three highly conserved base pairs (Fig. 14).80 Interestingly, 
the interactions with two of the three conserved base pairs are through main-
chain rather than side-chain atoms (the carbonyl groups of Lys-17 and Lys-18), 
indicating that altered specificity cannot be achieved by simple side-chain 
substitution of these residues.80 
Other Zinc-Containing Nucleic Acid-Binding Proteins. 
The three classes of zinc-containing, DNA-binding proteins discussed 
above almost certainly represent an incomplete list. Several other DNA 
transcription factors, such as the GATA factor, RAG-1 and RAD-18 contain 
cysteine-rich regions that may serve as metal binding domains.2,51,52 In 
addition, a class of proteins related to the gag protein contain a small zinc-
binding motif often referred to as the "retroviral knuckle."2,51,52 The 
structure of the Cd2+ form of an 18 residue peptide from HIV gag has been 
determined by NMR; it is distinct from any of those described above.83 
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LEUCINE ZIPPER AND HELIX-LOOP-HELIX PROTEINS 
Basic Region-Leucine Zipper Proteins. 
A class of transcriptional activators and oncogenic proteins known as 
basic region-leucine zipper (bZIP) proteins were originally identified based on 
the sequence similarity of their dimerization domains.84 As a thorough 
review of bZIP proteins is presented in Chapter Two, only a brief outline will 
be given here. The cocrystal structure of the bZIP domain of the yeast 
transcriptional activator GCN4 in complex with its DNA binding site has 
been solved.85 Like GAL4, it contains a coiled-coil dimerization domain that 
is perpendicular to the DNA helix axis; however, in the GCN4 complex, this 
domain approaches the major groove.85 Furthermore, no extended linker 
separates this domain from the basic region that makes specific and non-
specific contacts with the DNA. Instead, the a.-helices of the coiled-coil 
diverge smoothly and each monomer tracks along the major groove, 
resulting in a Y-shaped a.-helical structure (Chapter Two, Fig. 8).85 In contrast 
to GAL4, the dimerization domain of bZIP proteins forms a stable structure, 
but the basic region is largely disordered in the absence of DNA.86-92 
Helix-Loop-Helix Proteins. 
A number of transcriptional activators important in cell differentiation 
and growth control include a conserved element known as the helix-loop-
helix (HLH) in their DNA-binding domains.93 Two amphipathic a.-helices 
linked by a loop of various lengths are found in this region, and it was 
proposed to serve as a dimerization domain.93 Like the bZIP proteins, these 
HLH proteins contain a bipartite DNA binding domain consisting of a 
conserved basic region followed immediately by a dimerization domain, the 
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HLH.94 One subclass of basic region-HLH (bHLH) proteins, including the c-
Myc protein, also contain a leucine zipper region immediately C-terminal to 
the HLH element (Fig. 15).95 For these proteins, both the HLH and zipper (Z) 
regions are required for dimerization and DNA binding.95 The protein-DNA 
structure for the DNA binding domain of one of these b/HLH/Z proteins, 
Max, has recently been reported.96 Max serves as the dimerization partner for 
Myc, but unlike Myc, it can form homodimers and recognize DNA sequence-
















Figure 15. Amino acid sequences of the b/HLH/Z proteins Myc and Max and 
the b/HLH protein MyoD. The basic, HLH, and zipper regions are indicated. 
Conserved residues are printed in bold type. Sequences and alignment were 
taken from reference 95. 
The overall structure of the Max-DNA complex is reminiscent of the 
GCN4-DNA complex, approaching the major groove of DNA with a helical 
dimerization domain and positioning the basic region of each monomer 
appropriately for major groove contacts with a DNA binding site consisting of 
abutted inverted repeats (Fig. 16).96 Unlike GCN4, Max contains a globular 
domain, the HLH dimerization domain, which forms a novel parallel four-
helix bundle, a structure similar to those predicted by model building.99-101 
This structure is inconsistent with an antiparallel four-helix model based on 
NMR studies of an oxidized MyoD dimer. However, oxidized MyoD binds 
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DNA less actively than reduced MyoD and may not reflect the structure of the 
HLH upon DNA binding.102 
Figure 16. Schematic views of (left) the MAX-DNA complex and (right) the 
contacts made by a MAX monomer with its half site.96 
Amino acid residues in the basic regions of Max make major groove 
contacts with each of the three bases in each half site as well as phosphate 
interactions spanning over six base pairs in each half-site in a manner similar 
to that seen with GCN4 (Fig 16).96 Unlike GCN4, Max uses residues outside 
the basic region, including Arg-47 and Lys-57 in the loop region and Arg-60 at 
the start of the second HLH helix, to make phosphate contacts.96 Lys-25 
interacts with the minor groove, prompting the suggestion that proteins 
with long loop regions could make specific contacts with the adjacent minor 
groove, expanding the sequence selectivity of such proteins beyond the 
standard six base pair recognition element.96 No contacts are made by the 
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zipper region, suggesting that bHLH proteins lacking a zipper domain will 
interact with the DNA very much as Max does.96 As with GCN4, the DNA 
exhibits only minor deviations from B-form.96 
BET A-RIBBON PROTEINS 
Although a-helices provide the major source of protein-DNA contacts for 
the classes of DNA-binding proteins discussed above, other classes of proteins 
bind to their recognition sites through the use of 13-sheet structure.1 ,2, 103 
One such class of proteins includes the prokaryotic Met, Arc, and Mnt 
repressor proteins, and possibly the E. coli Tra Y proteins.104,105 Mnt, Met 
and Arc repressors all bind as tetramers to 17 to 20 base pair operator sites.106-
109 The solution structure of Arc repressor has been determined, and the 
crystal structure of the Met repressor-operator complex is available.104,108,110 
In spite of only weak primary sequence homology (Fig. 17), the structures of 
the Arc and Met repressors are very similar; both form highly intertwined 
dimers in which residues near the NH2-terminus of each monomer form an 
antiparallel 13-sheet.104,108 
<SHEET-> <---HELIX----> <--HELIX---> 
Met ... GKKSEQVKKITVSIPLKVLKILTDERTRRQVNNLRHATNSELLCEAFLHAFTGQPLPD .. . 
Arc MKGMSKMPQFNLRWPREVLDVLRKVAEEN GRSVNSEIYQRVMESFKKEGRIGA 
Mnt ARDDPHFNFRMPMEVREKLKFRAEAN GRSMNSELLQIVQDALSKPSPVTG 
Figure 17. Sequences of the 13-ribbon repressors. Regions of regular secondary 
structure are indicated. Sequences and alignment from reference 104. 
In the Met repressor-DNA structure, two dimeric repressor molecules 
bind to adjacent direct repeats of eight base pairs with inter-dimer contacts 
suggestive of cooperative binding.110 Each repressor dimer binds with its 13-
ribbon inserted into a compressed major groove making direct hydrogen 
bonds to the ON A bases, as predicted by a model based on the Arc sol uti on 
structure (Fig. 18).104,110 The 13-ribbon is the primary source of sequence-
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specific interactions, consistent with biochemical and genetic data for all three 
repressors.106,111-114 However, many of the nonspecific phosphate contacts 
are made by residues in other segments of the protein, including the 
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Figure 18. (Left) Ribbon diagram of the Met repressor-operator complex. 
(Right) Schematic view of the contacts made by a Met repressor dimer with its 
DNA site.110 
It has been proposed that another group of DNA-binding proteins 
interacts with the minor groove of DNA through a J3-ribbon motif.1,2, 103 
The structure of a nonspecific histone-like protein, HU from E. coli, has been 
determined; the dimeric molecule has two symmetrically related J3-arms 
positioned appropriately for DNA contacts.115 The closely related DNA 
bindng protein IHF binds to DNA sequence-specifically in the minor groove, 
and a model has been proposed for the structure of its complex with DNA 
based on biochemical data and the HU structure.116,117 Further structural 
studies will be required to test this model. 
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OTHER TRANSCRIPTIONAL ACTIVATORS 
The cocrystal structures of the DNA-binding domains of the TATA-
binding protein (TBP) and of the bovine papillomavirus E2 transcriptional 
activators complexed with DNA have been determined recently)18-120 
These DNA-binding domains bear no resemblance to those listed above, and 
although they are unlikely to represent general classes of DNA-binding 
proteins, their novel structural features are of interest. 
Figure 19. (Left) Ribbon diagram of the E2-DNA complex. (Right) Schematic 
view of the base contacts made by an E2 monomer at its DNA half site?,118 
The E2 protein is a transcriptional activator found in papillomaviruses; 
an 85 amino acid C02H-terminal domain from E2 is sufficient for both 
sequence-specific DNA binding and dimerization.121-123 The crystal 
structure of the E2-DNA complex reveals an unprecedented dimeric 
antiparallel J3-barrel with four strands contributed by each monomer. In 
contrast to the Met repressor, which uses a largely a-helical scaffold to present 
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a 13-arm to the DNA, the 13-barrel of E2 presents of pair of symmetrically 
related a-helices to the major grooves of each half site (Fig. 19).118 Contacts 
to the bases are made by four conserved amino acid residues in each 
recognition helix, including an unprecedented hydrogen bond between the 
cysteine sulfhydryl group and 06 of guanine (Fig. 19).118 In addition, a 
remarkable 10 direct and 14 water-mediated phosphate interactions are made 
with each half site, requiring significant DNA bending.l18 Unlike the 
bending observed in the prokaryotic HTH proteins, such as CAP, where the 
bending is localized mainly to two large kinks,19 the DNA is smoothly bent 
with both major and minor grooves compressed on the concave side of the 
DNA that faces the protein.l9 
The TATA-binding protein, also known as TFIID, is required for 
transcription by all three eukaryotic RNA polymerases. The structure of TBP 
from Arabidopsis thaliana was reported in 1992; its structure is shown in 
Figure 20A.124 It is a saddle-shaped structure with two symmetrically related 
and structurally similar domains of approximately 90 amino acids, each 
consisting of a five-stranded 13-sheet and two a-helices.124 On the basis of 
modeling studies, it was predicted that the DNA bound to the underside of 
TBP at a right angle to the long axis of the protein.124 
The cocrystal structures of both the A. thaliana TBP and the DNA-binding 
domain of yeast TBP have been reported very recently.119,120,125 Consistent 
with biochemical studies, the protein contacts the DNA in its minor groove, 
and the DNA helix is bent dramatically.126-128 However, the DNA lies at an 
angle of 90° from the predicted orientation, following the long axis of TBP 
and bending to complement the concave face of the protein.119 ,120 The 






Figure 20. (Left) Ribbon diagrams showing two 
structure of TBP in the absence of DNA. (Right) 
contacts made between TPB and the TATA box?,120 
5' 
different views of the 
Schema tic view of the 
allowing the protein to interact through its entire concave surface with its 
wide minor groove. Outside the TATA box, the DNA is suprisingly close to 
B-form; kinks between the first and second and seventh and eighth bases of 
the TATA box result from the wedging of two pairs of phenylalanine side 
chains between these base pairs.119,120 The contact surface is much more 
hydrophobic than is usually found in protein-DNA interfaces, and most of 
the stabilization appears to result through van der Waals contacts with the 
DNA bases and the ribose backbone moieties.119,120 There is an excellent 
correlation between residues contacting the DNA and mutations affecting 
DNA binding.119,120 "Indirect readout" of the protein sequence through its 
sequence-dependent deformability is proposed to contribute not only to the 
DNA-binding specificity of TBP, but perhaps also to determine the polarity 
with which the pseudosymmetric protein binds, with important 
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consequences for the binding of RNA polymerases and the directionality of 
RNA transcription.119 
CONCLUSION 
A key lesson to be taken from studies of sequence-specific DNA-binding 
proteins to date is that there is no simple recognition code for protein-DNA 
binding; that is, sequence specific binding is not achieved through predictable 
contacts of side chains with the edges of the DNA bases. Instead, a complex 
and cooperative network of interactions between the protein side chain and 
main chain atoms with the DNA backbone and bases is used for high affinity 
and selective DNA binding. Studies of a number of protein structural classes 
demonstrate that amino acid residues may interact to recognize a single base 
pair, and, conversely, a single residue may make contacts with more than one 
base pair. From structural studies of more than one member of a single class 
of DNA-binding proteins, such as HTH and TFIIIA-like zinc finger proteins, it 
is clear that substructures may dock against the DNA at a variety of angles, 
rendering predictions and manipulation of sequence specificity difficult. 
Some groups of classes of proteins, such as the homeodomain or some 
subclasses of TFIITA-like zinc fingers may provide a better starting point for 
the design or random selection of protein with altered sequence specificity. 
The large and growing number of structural classes of DNA binding 
proteins illustrates the broad range of structural scaffolds that may be used to 
present elements of secondary structure to DNA. Although the majority of 
these classes present a.-helices to the major groove of DNA, recent structures 
reveal the first examples of exclusive minor groove recognition119,120 and 
the use of f3-strand structure as a primary source of sequence specific 
30 
contacts.110 In addition, the importance of both protein and DNA flexibility 
in forming sequence specific complexes has become clear over the last several 
years.2,7,85 The recent explosion in the number of solved three-dimensional 
structures of protein-DNA complexes from a number of structural classes 
provides fertile ground for further chemical, genetic, and structural studies. 
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CHAPTER TWO 
STRUCfURAL INVESTIGATIONS OF LEUCINE ZIPPER 
PROTEINS BY AFFINITY CLEAVING 
Affinity Cleaving. 
One of the most common means of investigating the interaction of a 
DNA-binding molecule with its recognition site is through chemical or 
enzymatic footprinting (Fig. 1, left).l-4 In this technique, a DNA sample is 
allowed to react with a non-specific DNA-cleaving agent under conditions 
that result in the random cleavage of each DNA molecule at one position. If 
the 32P-end-labeled DNA products from such a reaction are subjected to 
polyacrylamide gel electrophoresis, a ladder of cleavage bands results. When 
the reaction is carried out in the presence of a specific DNA-binding molecule, 
cleavage is blocked at the positions to which the ligand binds, resulting in a 
"footprint" in the DNA cleavage ladder. Such experiments yield valuable 
information about the location and size of the DNA binding sites for a given 
DNA-binding molecule. 
- - S' 3' S' 3' - -- -- --- ---------- ..... - - --- - --- -- -S' 3' 5' 3' 
Figure. 1. Footprining and affinity cleaving assays. 
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A complementary technique known as affinity cleaving has been 
developed in the Dervan group (Fig. 1, right).s In this assay, the iron 
chelating agent EDTA is attached to a sequence-specific DNA-binding 
molecule to afford a sequence-specific DNA-cleaving molecule that functions 
at physiologically relevant pH, temperature, and salt conditions.2,3,6,7 
Following chemical activation with a reducing agent such as dithiothreitol 
(DTT), Fe•EDTA localized at a specific DNA binding site cleaves both DNA 
strands, typically over 4 to 6 base pairs, via a diffusible species, presumably 
hydroxyl radical (Fig. 1, right) .6,7 Because the cleaving moiety is not 
sequence specific, the cleavage specificity is derived from the binding 
specificity of the molecule under investigation. The location of the DNA 
cleavage provides information not only about the preferred binding sites of 
the DNA-binding molecule but also about its orientation at those sites. 
In addition, due to the right-handed nature of double helical DNA, the 
groove in which the Fe•EDTA is located can be identified by analysis of the 
cleavage patterns (Fig.2). An Fe•EDTA located in the minor groove generates 
an asymmetric cleavage pattern with maximal cleavage loci shifted to the 3' 
side on opposite strands (Fig. 2).6,7 When the Fe•EDTA is located in the 
major groove, the maximal cleavage loci are 5'-shifted; in addition, cleavage 
of lower efficiency occurs on the distal strands of the adjacent minor grooves 
(Fig. 2).8,9 This results in a pair of 3'-shifted asymmetric cleavage loci of 
unequal intensity on opposite strands (Fig.2).8,9 These patterns can be 
explained if the diffusible radical generated from the localized Fe•EDTA 
reacts in the major and minor grooves of DNA with unequal rates, 
preferentially (though not necessarily exclusively) in the minor groove10 or if 
the major groove is partially protected from cleavage by the presence of a 
bulky DNA-binding molecule. 
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Figure 2. Cleavage patterns produced by a diffusible oxidant generated by 
Fe•EDTA located in the major and minor grooves of right handed DNA. 
Filled circles represent points of cleavage along the phosphodiester backbone. 
Sizes of circles represent extent of cleavage. 
Affinity Cleaving Proteins. 
Because the DNA-recognition domains of many DNA-binding proteins 
are of a reasonable size for solid phase peptide synthesis 11, chemical methods 
have been developed in the Dervan group to attach EDTA to DNA-binding 
proteins through solid-phase methods.12-15 Incorporation of Fe•EDTA at 
discrete amino acid residues within a protein allows the positions of those 
residues in the protein-DNA complex relative to the DNA bases to be 
mapped. Such EDTA-equipped affinity cleaving proteins have been used to 
investigate the structure of the DNA binding domains of the putative helix-
turn-helix proteins Hin recombinase and yo resolvase.12,14,16,17 By attaching 
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Fe • EDTA to the NH2-termini of these proteins, the NH2-terminal amino acid 
residues have been mapped to the minor groove near the center of the 
dimeric binding sites.12,16,17 Peptides with Fe•EDTA attached near the 
C02H-terminus were used to determine the orientation of the putative 
recognition helices in the major groove of the binding sites14,17. In addition, 
the orientation of the recognition helix of the helix-turn-helix protein Lac 
repressor was confirmed using a protein modified with Fe•EDTA at its COzH-
terminus.18 These studies demonstrate the utility of affinity cleaving in the 
investigation of the structure of protein • DNA complexes. The studies 
described in this chapter extend the technique of affinity cleaving to another 
class of DNA bindng proteins, the basic region-leucine zipper (bZip) proteins. 
Basic Region-Leucine Zipper Proteins. 
A class of sequence-specific DNA binding proteins important in the 
regulation of gene expression is thought to bind DNA via a bipartite 
structural motif consisting of a DNA binding domain, termed the "basic 
region," and a dimerization domain, termed the "leucine zipper."19,20 This 
class of proteins was first proposed by Landschulz et al., who noted that 
several proteins, among them the transcriptional activators CEBP and GCN4, 
and the oncogenes Jun and Fos, contain a series of four or more heptad 
repeats of leucine.21 These leucines occurred in an extremely a.-helix 
permissive region. Recognizing that an a.-helical structure would lead to the 
alignment of the leucines along one face of the helix, forming a very 
hydrophobic surface, these investigators suggested that this "leucine zipper" 
region constitutes a dimerization domain that also anchors the peptide on the 
DNA. In agreement with this model, both GCN4 and CEBP form 
homodimers. 21 ,22 Similarly, Jun and Fos have been shown to form 
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heterodimers23-28, and Jun can also form homodimers.26,28 Furthermore, 
deletion and site-directed mutagenesis analyses have demonstrated that the 
leucine zipper region is absolutely required for dimerization and for 
interaction with DNA.23-33 
A basic region found immediately NH2-terminal to and at a fixed 
distance from the leucine zipper region is also highly conserved among many 
of the leucine zipper proteins (Figure 3).23-25,30,31 Compelling evidence of 
the importance of these basic residues was obtained in site-directed 
mutagenesis studies performed with several putative leucine zipper proteins. 
The mutation of groups of these basic residues to neutral residues severely 
affected the DNA binding affinities, but not the dimerization, of the Jun-Fos 
heterodimer, the Jun-Jun homodimer, and the CEBP homodimer.23-25,30,31 
These results supported the conclusion that the leucine zipper domain is 
necessary for dimerization, which is in turn required for DNA recognition, 


















PEEEE KRRIRR ERNKMAAAKCRNRRRELTDTLQAETDQLEDKKSALQTEIANLLKEKEKL 
PEEEE RRRVRR ERNKLAAAKCRNRRKELTDFLQAETDKLEDEKSGLQREIEELQRQKERL 
PEEEE KRRVRR ERNKLAAAKCRNRRRELTDRLQAETDQLEEKKAELESEIAELQKEKERL 
KNSNE Y RVRR ERNNIAVRKSRDKAKQRNVETQQKVLELTSDNDRLRKRVEQLSTELDTL 
QPAEE RKREVR LRNREAARECRRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHK 
EDPSD VVAMKR ARNTLAARKSRERKAQRLEELEAKIEELIAERDRWKNLALAHGASTE 
DKR KRNTAASARFRIKKKQREQALEKSAKEMSEKVTQLEGRIQALETENKWL 
Figure 3. The peptide sequences of putative leucine zipper DNA binding 
proteins. Conserved residues are printed in bold. Sources of sequences: 
GCN434,35, yAP1,36 jun,37 junB,38 junD,39,40 fos41,42, FRA143, fosB, 
44cEBP,45 CREB,46 cpc-1,47 cys-3.48 
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Studies using peptides corresponding to the leucine zippers of GCN4, Jun, 
and Fos helped to define this region. First, Kim and co-workers demonstrated 
the GCN4 monomers were largely a- helical and aligned in a parallel 
fashion to form homodimers. They further noted the presence of a 4-3 repeat 
characteristic of classical coiled-coil proteins and suggested that the "leucine 
zipper" dimerization domain assumes this structure.49 Similar 
investigations with the Jun and Fos leucine zippers confirmed that the 
dimerization specificity of the protein complexes is determined by this 
region.SO,Sl Finally, the three-dimensional X-ray crystal structure of the 
leucine zipper region of GCN4 was determined and found to consist of a 
parallel two-stranded coiled-coil as predicted.52 
The structure of the basic regions was probed through circular dichroism 
studies with intact bZip proteins, with peptides comprising the basic and 
leucine zipper regions, or with disulfide-linked basic region peptides. These 
studies demonstrated that this region is relatively disordered in the absence of 
DNA, but assumes an a-helical structure upon DNA binding.53-58 
Two detailed structural models consistent with these results were 
proposed.53,59 Although the models differ in their details, they have several 
major features in common. In both models, the leucine zippers form a 
parallel two-stranded coiled-coil running perpendicular to the axis of the 
DNA binidng site. The NH2-terminal end of this region projects into the 
major groove of DNA, allowing the dipoles of the a-helices to interact 
favorably with the phosphate backbone. At the junction of the leucine zipper 
and basic regions, the a-helices of the dimer diverge and begin tracking in 
opposite directions along the major groove of the DNA binding site, resulting 
in a bifurcated, Y-shaped structure. As the DNA recognition elements for this 
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class of proteins consist of directly abutted half sites, this would allow one 
monomer to contact each half of the binding site in a symmetric fashion. 
In their "scissors grip model," Vinson, Sigler, and McKnight proposed 
that the a.-helical basic region forms a kink in order to allow all of the 
conserved basic residues to interact with DNA.59 Specifically, they suggested 
the a.-helices are broken by conserved asparagine residues, after which a 
second pair of a.-helices begins at an angle of 75 degrees from the first. This 
structure would allow both halves of the DNA-binding domain to continue 
tracking along the major groove on the side opposite to that of their initial 
approach. 
The "induced helical fork" model, O'Neil, Hoess, and DeGrado, on the 
other hand, contains no break in the helical structure of the DNA binding 
domain. 53 In addition, these investigators proposed that the conserved 
asparagine, as well as two conserved alanines and a conserved cysteine/serine 
were involved in specific contacts with the DNA.53 
Both models proposed symmetrical contacts in the major groove of the 
palindromic DNA binding site.53,59 Footprinting, methylation interference, 
and ethylation interference studies were consistent with this proposal. 
However, at the time our initial work was published,60 relatively little other 
structural data were available. Recently, the three-dimensional structure of 
the GCN4-DNA complex has been reported.61 In the next section, our studies 
with GCN4 affinity cleaving peptides will be presented. Our results and 
conclusions will then be evaluated in light of the known structure of the 
GCN4-DNA complex in the following section. 
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STRUCTURAL MOTIF OF THE GCN4 DNA BINDING DOMAIN 
CHARACTERIZED BY AFFINITY CLEAVING 
This section describes the results of affinity cleaving studies designed to 
investigate the structure of the DNA binding domain of the yeast 
transcriptional activator GCN4, a putative basic region-leucine zipper (bZIP) 
protein. GCN4 is necessary for the coordinate induction of 30- 50 proteins 
involved in the biosynthesis of amino acids in response to amino acid 
starvation.62 A functional dissection of GCN4 has demonstrated that the 60 
amino acids at the C02H-terminus, residues 222 - 281, contain the specific 
DNA binding activity; however, 37 residues (245- 281) at the C02H-terminus 
were shown to be insufficient for DNA binding.63 GCN4 exists as a dimer 
and the C02H-terminal 60 residues are sufficient for dimerization.22 The 
optimum DNA binding site for GCN4 is 5'-rrTGACTcatt-3', where the 
underlined C corresponds to the center of pseudodyad symmetry.64,65 Struhl 
and co-workers have proposed that this pseudosymmetric site behaves as two 
half sites, noting that mutation of the naturally occurring GCN4 binding site 
5'-TGACTCT-3' to the perfectly palindromic S'TGACTCA-3' increases the 
affinity of the protein for the DNA, while all other mutations in this region 
lead to unchanged or decreased affinity. However, mutation of the TGACT 
bases leads to the greatest reduction in binding affinity, and mutation of the 
central C to G abolishes activity, implying that the protein-DNA interactions 
at each half site are not equat.64,65 
The DNA binding domain of the transcriptional activator GCN4, residues 
222-281, contains the putative "basic" and "leucine zipper" regions63. Four 
different proteins based on the DNA binding domain of GCN4 were 
synthesized by solid phase methods (Fig. 4).15 These proteins were 
incrementally shortened at the NH2-terminus and differ in length from 45 to 
45 
60 amino acid residues. GCN4(237-281), (232-281), (226-281), and (222-281) 
were synthesized with and without EDTA attached to the NH2-terminal 
residue for comparative affinity cleaving and footprinting studies of the 
corresponding protein-DNA complexes. 
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Figure 4. The sequence of 60 amino acids (222-281) corresponding to the C02H 
terminus of yeast transcriptional activator GCN4 listed from NH2 to C02H 
terminus. (B) Synthetic protein EDTA-GCN4(222-281). 
The GCN4 proteins were assayed for specific DNA binding and cleaving 
by analyzing the cleavage products from a restriction fragment containing two 
GCN4 recognition sites, termed ARE (5'-CTGACTAAT- 3') and GCRE 
(5'-ATGACTCTT-3').66 DNase I and MPE footprinting demonstrate that 
GCN4(222-281), (226-281), and (232-281) (60, 56, SOmers, respectively) bind 
specifically to DNA at a concentration of 5 IJ.M, whereas GCN4(237-281) 
(45mer) does not. Affinity cleaving experiments show that Fe•EDTA-GCN4 
50, 56 and 60mers cleave DNA specifically at 5 IJ.M concentrations. The GCN4 
SOmer binds DNA with reduced affinity compared to the longer proteins. 
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Figure 5. Autoradiogram of a high resolution denaturing polyacrylamide gel. 
Lanes 5-16 contain footprinting reactions with GCN4(222-281) and (226-281) 
and lanes 17-24 contain affinity cleaving reactions with 
Fe•EDTA-GCN4(222-281) and (226- 281). Odd numbered lanes are labelled 
with 32P at the 5'-end and even numbered lanes are labelled with 32P at the 
3'- end. Lanes 1 and 2, intact DNA control; lanes 3 and 4, chemical sequencing 
A reaction; lanes 5 and 6, DNase I control; lanes 7 and 8, DNase I cleavage 
protection in the presence of GCN4(222-281) at 5 J..LM; lanes 9 and 10, DNase I 
cleavage protection in the presence of GCN4(226-281) at 5 J..LM; lanes 11 and 12, 
MPE•Fe control; lanes 13 and 14, MPE•Fe cleavage protection in the presence 
of GCN4(222-281) at 5 J..LM; lanes 15 and 16, MPE•Fe cleavage protection in the 
presence of GCN4(226-281) at 5 J..LM; lanes 17 and 18, Fe•EDTA-GCN4(222-281) 
at 5 J..LM; lanes 19 and 20, Fe•EDTA-GCN4(222-281) at 1 J..LM; lanes 21 and 22, 
Fe•EDTA-GCN4(226-281) at 5 J..LM; and lanes 23 and 24, 
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Figure 6. The sequence from left to right represents the data between the two 
arrows from the bottom to the middle of the gel shown on the left in Fig. 5. 
(A) Bars represent the extent of protection from MPE • Fe cleavage in the 
presence of the GCN4(222- 281) (Fig. 5, lanes 13 and 14). Brackets represent 
bases protected from DNase I cleavage, and asterisks represent DNase I 
hypersensitivity sites (Fig. 5, lanes 7 and 8). (B) Arrows represent the extent 
of cleavage at the indicated base positions for Fe•EDTA-GCN4(222-281) at 5 
~M (Fig. 5, lanes 17 and 18). (C) Cleavage pattern for Fe•EDTA-GCN4(222-281) 
at 1 ~M (Fig. 5, lanes 19 and 20). (D) MPE•Fe and DNase I protection in the 
presence of GCN4(226-281) (Fig. 5, lanes 9, 10, 15, and 16). (E) Cleavage pattern 
for Fe•EDTA-GCN4(226-281) at 5 ~M (Fig. 5, lanes 21 and 22). (F) Cleavage 
pattern for Fe•EDTA- GCN4(226-281) at 1 ~M (Fig. 5, lanes 23 and 24). 
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There are ten positively charged residues in the basic region extending from 
Lys-231 to Lys-251. GCN4 45mer, which contains seven basic residues, is not 
able to bind to DNA; GCN4 SOmer, which contains nine basic residues, binds 
with reduced affinity, suggesting that the missing residues are important. 
GCN4 56mer and GCN4 60mer bind with approximately equal affinity. 
The footprinting and affinity cleaving results for GCN4(222- 281) and 
GCN4(226-281) are shown in gel form in Figure 5; the data are represented by 
histograms in Figure 6. Both proteins protect regions of approximately 18 
base pairs at the ARE and the GCRE binding sites from DNase I and MPE•Fe 
cleavage, demonstrating sequence specific binding (Fig. 5, lanes 5-16, Fig. 
6A,D). Fe•EDTA-GCN4 56 and 60mers give cleavage patterns centered at 
those sites (Fig. 5, lanes 17-24; Fig. 6B,C,E,F). The GCN4 56 and 60mers have 
greater affinity for the GCRE site than for the ARE site. This is in contrast to 
results reported for the entire GCN4 protein which apparently binds to both 
sites with equal affinity.66 
Because both halves of the Fe•EDTA-GCN4(222-281) and (226- 281) dimers 
contain Fe•EDTA at the NH2-terminus, the affinity cleavage pattern should 
result from the sum of two localized Fe•EDTA moieties. The cleavage 
pattern observed consists of three cleavage loci of unequal intensity. With 
regard to the cleavage model in Figure 2, the simplest interpretation of this 
cleavage pattern is that it results from the superimposition of two adjacent 
major groove cleavage patterns along one face of the DNA (Fig. 7 A). 
Cleavage occurs on both strands in three adjacent minor grooves, with the 
most efficient cleavage in the central minor groove proximal to both 
Fe•EDTA moieties. These data strongly suggest that the two Fe•EDTA 
moieties are located in adjacent major grooves. The positions of the 
Fe•EDTA moieties may be assigned by assuming that they lie in the center of 
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Figure 7. (A) Location of the two Fe•EDTA moieties at the NH2- termini of a 
GCN4(222-281) dimer assigned from the cleavage patterns for 
Fe•EDTA-GCN4(222-281) on the GCN4 binding site, 5'- ATGACTCTT-3' . 
Filled circles represent the positions of cleavage along the phosphodiester 
backbone. Sizes of circles represent the extent of cleavage at the indicated base 
position. (B) Front view of a Y-shaped model (11) for the dimer of the DNA 
binding domain of GCN4 terminating with Fe•EDTA at the NH2- termini. 
(C) Side view. The leucine zipper dimerization domains are represented by a 


































the two 5'-shifted patterns. The Fe•EDTA moieties, and hence the NH2 
termini of the dimer, are nine to ten base pairs apart and are located four to 
five base pairs on either side of the central C in the binding sites 5' -
CTGACTAAT-3' and 5'-ATGACTCTT- 3' (Fig. 7). The cleavage patterns at the 
ARE and GCRE sites are similar and indicate that the protein dimer binds the 
two sites in much the same way. 
Close scrutiny of the cleavage patterns reveals that the DNA cleavage by 
Fe•EDTA-GCN4(226-281) is more efficient than that by GCN4(222-281). This 
difference is especially noticeable at 1 J..LM concentrations, but it is found at all 
sites at all concentrations (Fig. 5, lanes, 19, 20, 23, 24). As the footprinting data 
indicate that the proteins bind with roughly equal affinity, this difference in 
cleavage intensity may indicate that the Fe•EDTA is closer to the DNA when 
it is attached to Asp-226. One curious aspect of our data is that the Fe•EDTA 
moiety appears to be located in approximately the same base pair position 
whether it is attached to Pro-222 or to Asp-226. A secondary structural 
element could bring these two residues in near enough proximity for the 
Fe•EDTA moiety to give similar cleavage patterns.67 
Affinity cleaving indicates that the NH2-termini of the GCN4(222-281) 
dimer are (1) in the major groove of DNA, (2) separated by nine to ten base 
pairs, and (3) symmetrically displaced four to five base pairs from the central 
C of the recognition site (Fig. 7B,C). This experimental result places the 
NH2-termini in successive major grooves on one face of the DNA, and is 
consistent with the proposed Y-shaped models for the structure of bZIP 
proteins.53,59 
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Figure 8. Cocrystal structure of the GCN4-DNA complex.61 The protein 
monomers are shown as ribbons and the DNA is shown as a CPK modeL 
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Figure 9. GCN4-DNA contacts. Phosphates contacted are represented as filled 
circles. A. Left half site monomer. B. Right half site monomer. C. DNA 
binding site numbering scheme. Adapted from Reference 61. 
THREE-DIMENSIONAL STRUCTURE OF THE GCN4-DNA COMPLEX 
The crystal structure of the GCN4 56mer, GCN4(226-281), in a complex 
with its DNA binding site has been determined recently by Harrison and co-
workers (Fig. 8).61 The protein does indeed have a Y-shaped structure with 
each monomer forming a smoothly curving cx.-helix.61 The structure of the 
coiled-coil leucine zipper region is much the same as in the isolated leucine 
zipper,52 and this region approaches the DNA helix at an angle of nearly 90 
degrees.61 The basic regions track through the major groove of each half site 
with no sharp bend or kink in this region, in general agreement with the 
predicitons of the induced helical fork model.53 
Numerous amino acid residues, ranging from Arg-232 to Arg-249 (Fig. 4), 
make contacts with the DNA binding site. The contacts are similar, but not 
identical in the two half sites (Fig. 9).61 Specific contacts include hydrogen 
bonds between the amido group of Asn-235 and N4 of Cyt-2 and 04 of Thy-3; 
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van der Waals contacts between the methyl side chains of Ala-238 and Ala-
239 with the 5-methyl groups of Thy-3 and Thy-1, respectively; and a pair of 
hydrogen bonds between Arg-243 of the left half site monomer and 06 and N7 
of Gua-o·.61 
Of the GCN4 peptides synthesized in our affinity cleaving studies, only 
pep tides of 50 amino acid residues or longer bound to DNA. The 45mer, 
GCN4(237-281), lacks Asn-235, which makes specific DNA contacts, as well as 
Arg-232 and Arg-234, which make non-specific contacts with the DNA 
backbone, explaining its inability to bind DNA. The SOmer, GCN4(232-281), 
on the other hand, contains all the residues involved in contacts to the DNA, 
but binds with reduced affinity compared to the 56mer and 60mer. The 
reduced binding affinity of the SOmer could be explained by a destabilization 
of the complex by unfavorable interactions between the negatively charged 
Fe•EDTA complex and the phosphodiester backbone. 
The crystal structure shows that Asp-226 is three turns of the a-helix away 
from the residues that contact bases at the DNA binding site.61 Although it is 
somewhat surprising that an interpretable cleavage pattern results from an 
Fe•EDTA moiety held so far away from the DNA, our experiments imply 
that it is not necessary to position an Fe • EDT A precisely in order to obtain 
structural information about a protein-DNA complex. On the other hand, 
the distance between Asp-226 and the DNA explains the lack of cleavage by 
Ni(ll)•Gly-Gly-His-GCN4(226-281) (data not shown), as Gly-Gly-His cleaves 
DNA through a nondiffusible oxidant.68,69 The fact that the protein extends 
away from the DNA helix also explains the cleavage by all three proteins at 
the same nucleotide positions, in contrast to the shifting cleavage patterns 
observed with Hin affinity cleaving proteins of varying lengths .16 
Interestingly, the SOmer, which should position the Fe•EDTA closest to the 
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Figure 10. Cocrystal structure of the GCN4-DNA complex showing the 
relative positions of Asn-226 and DNA backbone positions cleaved by 
Fe•EDTA-GCN4(226-281). The protein monomers are represented as ribbons, 
with the positon of Asn-226 highlighted in yellow. The nucleotides 
highlighted in yellow correspond to the sites of maximal cleavage by 
Fe•EDTA-GCN4(226-281) along the DNA backbone. The complex has been 




DNA gives the weakest cleavage pattern. Quantitative affinity cleaving 
titration experiments70-72 could be used to determine whether the poor 
cleavage is largely the result of poor binding or if the DNA is protected from 
cleavage in the major grooves by the protein. 
The DNA base positions of maximal cleavage by Fe•EDTA-GCN4(226-281) 
are highlighted in the GCN4-DNA structure shown in Figure 10 as are the 
two Asn-226 residues. The Asn-226 residues are in the major groove and 
symmetrically displaced from the center of the DNA binding site, as predicted 
by our analysis. They are most closely situated to phosphates 6 and 2' of either 
half site,61 in general agreement with our cleavage patterns, which are 
centered in each half site, 4-5 nucleotides away from the central C-G base pair. 
Interestingly, Ellenberger et al. point out that our data are more compatible 
with the induced helical fork model than with scissors grip model, which 
would predict that Asn-226 would be located farther from the center of the 
binding site.61 
AFFINITY CLEAVING INVESTIGATIONS OF JUN AND FOS DIMERS 
Introduction. 
The basic region-leucine zipper proteins v-Jun and v-Fos were originally 
identified as the cellular counterparts of the transforming factors from the 
avian leukemia and FBJ murine sarcoma viruses, respectively.37,41,42 Both 
Jun and Fos are nuclear phosphoproteins and are members of a group of 
factors known as APl which can act to stimulate transcription from genes that 
are responsive to tumor promoters. 73 The enhancers of these tumor 
promoter responsive genes contain the APl recognition site, 5'-TGAC/GTCA-
3', a site which is identical to the consensus recognition site for GCN4.64,73 
6I 
Because API is a heterogeneous mixture of proteins, the presence of Jun or 
Fos in this mixture does not prove it activates transcription directly. 
However, Jun has been shown to activate transcription from phorbol ester 
responsive promoters in vivo32,74 and its transcriptional activity is 
dramatically increased in the presence of Fos.32 
As discussed above, it has been shown by many investigators that Jun and 
Fos can form heterodimers 23-28 and that the leucine zipper region is critical 
for dimerization and for DNA binding.23-33 Jun can also bind to DNA 
specifically as a homodimer.26,28 Although Fos appears to be incapable of 
binding to its recognition site in the absence of Jun,25,27,75 it has been 
reported to stimulate the binding activity of Jun by factors ranging from 30- to 
1000-fold.23,25,27,3I,32,38,74 As Fos contains a basic region very similar to 
that of Jun and GCN4, it is believed that its lack of DNA binding activity 
reflects its inability to form homodimers.26 
Indirect evidence that the basic regions of Fos can interact with ON A 
comes from studies of chimeric leucine zipper proteins. A number of 
researchers have reported that chimeric proteins containing the basic region 
of Fos and the leucine zipper region of Jun are capable of forming 
homodimers or heterodimers with Jun. Both dimers contain two Fos 
binding regions and interact specifically with API sites?6-78 Similarly, a 
chimera (FosG) containing the leucine zipper of GCN4 and the DNA binding 
domain of Fos forms homodimers or heterodimers with GCN4 and binds to a 
GCN4/ AP1 site.79 Interestingly, in all cases, dimers with two Fos basic 
regions interact less strongly than those with a Jun and a Fos basic region, 
implying that the complex interacts asymmetrically with its palindromic 
binding site. As the dimerization domains are the same in both cases, it has 
been suggested that Fos has stronger affinity for one half site than the other, 
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leading to decreased binding efficiency when it is forced to interact with both 
half sites. 76 FosG homodimers also bind with lower affinity than GCN4 
homodimers or heterodimers of GCN4 and FosG?9 Again, the dimerization 
domains are identical in all three cases, indicating that the interaction of two 
basic regions from Fos leads to decreased binding affinity. 
Crosslinking studies have provided direct evidence that Fos can associate 
with DNA.80,81 Furthermore, crosslinking results with bromouridines 
substituted for specific thymidines in the binding site indicate that Fos binds 
preferentially to one half site. Asymmetry of binding by leucine zipper 
peptides has been suggested previously due to the asymmetry of the effects of 
mutations in the palindromic binding site.64,82 The recent GCN4 crystal 
structure shows that contacts between the half sites are indeed asymmetric, 
with only one monomer making base-specific contacts to the central C-G base 
pair (Fig. 8).61 As Jun, Fos, and GCN4 are highly homologous in their basic 
regions (Fig. 11), it has been proposed that the contacts made by the Jun-Fos 
heterodimer to the AP-1/GCN4 bindings site will be essentially the same as 
those made by GCN4.61 A preferential interaction by the Fos or Jun basic 
region with the guanine of the central base pair would explain preferred 








Figure 11. Conservation of amino acid residues making DNA contacts in the 
GCN4-DNA complex.61 Asterisks indicate residues making contact in both 
monomers; "R" indicates contacts made only by the right half site monomer. 
Using affinity cleaving on a heterodimeric protein, it is possible to test 
this asymmetric binding model directly (Fig. 12). If Fos exhibits a preference 
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Figure 12. Difference between cleavage patterns expected for a homodimer 
with Fe•EDTA on each monomer (A) and for a heterodimer containing only 
one monomer with Fe•EDTA (B) . If the heterodimer binds only in the 
orientation shown, it should result in the affinity cleavage pattern seen on 
the right. If it binds equally well in either orientation, a cleavage pattern 
resulting from two major groove Fe•EDTA moieties (left) will be obtained. 
for one half of the binding site over the other, then affinity cleaving by a 
dimer containing only one Fe•EDTA moiety should result in a standard 
major groove cleavage pattern at one half site (Fig. 128). However, if there is 
no polarity in binding, then the Fe•EDTA moiety should be equally 
distributed in both half sites. In this case, a homodimer-like cleavage pattern 
resulting from the superimposition of two major groove Fe•EDTA moieties 
will be observed (Fig. 12A). These affinity cleaving studies will also 
investigate the relative DNA affinity and specificity of Jun-Jun homodimers, 
Fos-Fos homodimers, and Jun-Fos homodimers. In addition, if any of these 
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protein dimers interacts with the DNA in a different fashion than GCN4, 
these differences should be reflected in the cleavage patterns. 
Preliminary Investigations. 
In order to address these questions, three Fos peptides and three Jun 
peptides were synthesized (Fig 13). These peptides correspond to the 50, 56, 
and 60mers of GCN4 (Fig 4) with an extra seven residues at the C02H-
terminus. Although these seven residues do not constitute a leucine repeat 
as such, they do contain hydophobic residues in the proper positions for 
formation of a coiled coil, and deletion of this region of Fos has been shown 
to reduce DNA binding.23 Kim and co-workers have also included these 
additional residues in their studies of the Jun and Fos leucine zippers.50 
Fos(134-200), Fos(139-200) and Fos(144-200) were prepared from a single 
manual synthesis; the C02H-terminal histidine was replaced by tyrosine in 
order to facilitate determination of peptide concentrations. Jun(212-280), 
Jun(218-280), and Jun(224-280) were synthesized from a single automated 
synthesis with poorer than average yields as measured by quantitative 
A.Jun 
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Figure 13. The sequences from NH2 to C02H terminus of the Jun and Fos 
peptides synthesized. Arrows indicate the NH2-termini of each peptide made; 
numbers indicate the length. A. Jun (212-280). B. Fos(134-200). 
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ninhydrin analysis.83 All six peptides were prepared both with and without 
EDTA at the NH2-termini. Because purification of the Jun peptides by 
preparative reverse phase HPLC did not result in pure fractions as assayed by 
analytical reverse phase HPLC, partially purified material was used in 
preliminary investigations. 
Unexpectedly, only the two longest EDTA-containing proteins, EDTA-
Jun(212-280) and EDTA-Fos(134-200), cleave DNA specifically as homodimers 
(data not shown). Because the homology with GCN4 extends through the 
regions corresponding to the smaller of these peptides (Fig. 3), it was expected 
that these peptides would be more likely to cleave DNA than would the 
longer peptides. Both Jun and Fos contain basic amino acid residues NH2-
terminal to the region of strongest homology with GCN4, and these residues 
could be required for binding. Attempts to measure binding of any of the 12 
proteins by DNAse or MPE footprinting were unsuccessful. 
DNA affinity cleaving results obtained with EDTA-Jun(212-280) and 
EDTA-Fos(134-200) are shown in gel form in Figure 14, and selected lanes are 
displayed in histogram form in Figure 15. Cleavage by EDT A-GCN4 56mer is 
shown for comparison. Both EDTA-Jun and EDTA-Fos homodimers are able 
to cleave DNA at the GCRE but not at the ARE. A much higher 
concentration of EDTA-Jun is required than of EDTA-Fos (5 JJ.M). For the 
lanes in which heterodimers were allowed to form, Jun and Fos were 
incubated for one hour at 37° in the absence of DNA. No attempt was made 
to purify heterodimers. Instead, only one of the peptides in each heterodimer 
affinity cleaving reaction was equipped with EDTA and heterodimer 
formation was driven by an excess of the peptide without EDTA. DNA 
cleavage should therefore result primarily from the heterodimer. The use of 
high concentrations of the protein not equipped with EDTA led to decreased 
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Figure 14. Autoradiogram of a high resolution denaturing polyacrylamide 
gel. Lanes 1-14 are labeled with 32P at the 5'-end and lanes 15-28 are labelled 
with 32P at the 3'- end. Lanes 1 and 15, intact DNA control; lanes 2 and 16, 
chemical sequencing A reaction; lanes 3 and 17, EDTA-Jun(212-280) at 10 J.LM; 
lanes 4 and 18, EDTA-Jun(212-280) at 10 J.LM and Fos(134-200) at 10 J.LM; lanes 5 
and 19, EDTA-Jun(212-280) at 10 J.LM and Fos(134-200) at 20 J.LM; lanes 6 and 20, 
EDTA-Jun(212-280) at 20 JJ.M; lanes 7 and 21, EDTA-Jun(212-280) at 20 J.LM and 
Fos(134-200) at 40 J.LM; lanes 8 and 22, Fe•EDTA-GCN4(226-281) at 5 J.l.M; lanes 
9 and 23, EDTA-Fos(134-200) at 2.5 J.l.M; lanes 10 and 24, EDTA-Fos(134-200) at 
2.5 J.LM and Jun(212-280) at 5J.1M; and lanes 11 and 25, EDTA-Fos(134-200) at 2.5 
J.l.M and Jun(212-280) at 10J.1M; lanes 12 and 26, EDTA-Fos(134-200) at 2.5 J.LM 
and Jun(212-280) at 20 JJ.M; lanes 13 and 27, EDTA-Fos(134-200) at 5 J.l.M; lanes 
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Figure 15. The sequence from left to right represents the data between the two 
arrows from the bottom to the middle of the gel shown on the left in Fig. 8. 
Arrows represent the extent of cleavage at the indicated base position for (A) 
EDTA-Jun(212-280) at 10 ~M and Fos(134-200) at 10 ~M (Fig. 13, lanes 4 and 18) 
(B) EDTA-Jun(212-280) at 20 ~M (Fig. 13, lanes 6 and 20) (C) 
Fe•EDTA-GCN4(226-281) at 5 ~M (Fig. 13, lanes 8 and 22 ). (D) EDTA-Fos(134-
200) at 2.5 ~M and Jun(212-280) at 10 ~M (Fig. 13, lanes 11 and 25). (E) EDTA-
Fos(134-200) at 5 J.1M (Fig. 13, lanes 13 and 27). 
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cleavage (Fig. 14, lanes 12 and 26), presumably due to significant binding by 
the unmodified homodimer. 
The high ratio of background cleavage to specific cleavage seen in many 
lanes in the gel is reproducible and precludes a quantitative assessment of 
these data. In addition, there is a concern about the purity of the Jun peptides. 
However, several qualitative conclusions may be drawn. First, leucine zipper 
and basic region domains of Jun and Fos are sufficient for specific DNA 
binding. Second, the DNA binding domains of both Jun and Fos are capable 
of binding to DNA in the absence of the other protein. While it is formally 
possible that Jun and Fos bind to DNA as monomers, this is unlikely. In 
either case, the result is at odds with previous studies concerning the inability 
of Fos to form dimers26 and bind to specific sequences of DNA.26-28,74 Kim 
and colleagues, however, have determined that peptides corresponding to the 
leucine zipper region of Fos are capable of forming both homo- and 
heterodimers.SO The Fos-Fos homodimer is much weaker than the Jun-Jun 
and Jun-Fos dimers, but Fos can exist as a homodimer at room temperature 
with a dissociation constant of about 6 J.LM.SO Such concentrations are much 
higher than those used in in vitro translation experiments, but approximately 
equivalent to the conditions used in these affinity cleaving studies.S 0 
Considering this data and the fact that Fos 67mer is able to interact with DNA 
at lower concentrations than the Jun 69mer, which is known to form 
homodimers, it is most reasonable to assume that Fos binds as a dimer. 
A third conclusion to be drawn from the data shown in Figures 14 and 15 
is that Jun-Fos heterodimers appear to form, as is evidenced by a clear change 
in DNA binding affinity. It is not possible to determine from this data 
whether the appearance of binding activity for the ARE is due to a change in 
sequence specificity or simply to increased affinity for DNA: GCN4 binds to 
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the GCRE and to the ARE at concentrations of 5 j.J.M, while binding only to the 
GCRE at a concentration of 1 IJ.M (Fig. 5). An interesting feature of the EDTA-
Jun(212-280) + Fos(134-200) and EDTA-Fos(134-200) + Jun(212-280) cleavage 
patterns (Figure 15A and 15D) is that the interaction of the heterodimers with 
the two sites is markedly different. This is in contrast to GCN4, which 
interacts with both sites in a similar fashion . Although no polarity in binding 
is exhibited by Jun-Fos heterodimers at the ARE, it appears that EDTA-
Fos(134-200) + Jun(212-280) cleaves with lower intensity at the 5'-CTCTI-3' 
half of the binding site than at the 5'-ATGAC-3' half site, as does the EDTA-
Fos(134-200) homodimer. Conversely, the EDTA-Jun(212-280) + Fos(134-200) 
heterodimer leads to greater cleavage intensity at the 5'-CTCTT-3' half of the 
binding site than at the 5'-ATGAC-3' half site. The EDTA-Jun(212-280) affinity 
cleaving data is difficult to interpret due to the low cleavage intensity, but the 
intensity of cleavage appears to be approximately equal at each half site. Thus, 
it is possible that the apparent polarity of Jun-Fos heterodimer binding at the 
GCRE results from the preference of Fos to bind to the 5'-ATGAC-3' half site 
(or to avoid the 5'-CTCTI-3' half site). 
A.Jun 
69 67 65 63 60 58 





Figure 16. The sequences from NH2 to C02H terminus of (A) Jun (212-280) 
and (B) GCN4(222-252)-Fos(165-200). Arrows indicate the NH2-termini of 
each Jun peptide made; numbers indicate the length. 
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Further Studies. 
Jun was resynthesized in hopes of obtaining more conclusive data. In 
order to explore the length dependence of affinity cleaving, a series of six Jun 
proteins was prepared, ranging in length from 58 to 69 residues (Fig. 16A). In 
addition, a chimeric protein, GCN4(222-252)-Fos(165-200) (GBR-FZIP), 
consisting of the leucine zipper of Fos and the basic region of GCN4 was 
synthesized (Fig. 16B). Each protein was sythesized with and without EDTA. 
Both syntheses gave acceptable yields and upon purification afforded a single 
peak by analytical HPLC. However, this sample of Fe•EDTA-Jun(212-280) 
(69mer) provided data at least qualitatively indistinguishable from that 
previously obtained with apparently less pure material. The Fos proteins 
were identical to those used in the last section. Again, the signal-to-noise is 
poor, and pure heterodimers were not isolated, allowing only for qualitative 
conclusions from the data. 
The length dependence of Jun-Fos homo- and heterodimer formation 
and DNA cleavage was explored with the truncated Jun peptides. The 
Fe•EDTA-Jun(212-280) (69mer) cleaved as a homodimer at the GCRE at 10 
J.!.M, and cleavage fell off with length; no specific cleavage was seen for the 60-
and 58mers (Fig. 17, lanes 5-16). Only the 69mer showed cleavage, though 
very weak, at the ARE. Although previous studies indicated that truncated 
Jun peptides could not form heterodimers with truncated Fos peptides, all six 
Fe•EDTA-Jun proteins cleaved DNA both at the ARE and at the GCRE in the 
presence of 20 JJ.M Fos(134-200) (67mer; Fig 17, lanes 5-16). The cleavage 
patterns are similar in each case and show the same asymmetry at the GCRE 
noted above. The results for the Fos proteins were different (Fig. 17, lanes 17-
22). As with Jun, at a concentration of 10 J.!.M, the longest Fe•EDTA-Fos pro-
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Figure 17. Autoradiogram of a high resolution polyacrylamide gel. All lanes 
contain 3'-32P-end-labeled DNA unless otherwise noted. Lane 1, DNA 
standard. Lanes 2 and 3, 5'- and 3'- A-specific sequencing reactions. Lane 4, 
Fe•EDTA-GCN4(226-281), (5 ).l.M). Lane 5, Fe•EDTA-Jun 69mer (10 ).l.M). Lane 
6, Fe•EDTA-Jun 69mer (10 ).l.M) and Fos(134-200) (20 ).l.M). Lane 7, Fe•EDTA-
Jun 67mer (10 ).l.M). Lane 8, Fe•EDTA-Jun 67mer (10 ).l.M) and Fos(134-200) (20 
).l.M). Lane 9, Fe•EDTA-Jun 65mer (10 ).l.M). Lane 10, Fe•EDTA-Jun 65mer (10 
).l.M) and Fos(134-200) (20).1.M). Lane 11, Fe•EDTA-Jun 63mer (10 ).l.M). Lane 12, 
Fe•EDTA-Jun 63mer (10 ).l.M) and Fos(134-200) (20 ).l.M). Lane 13, Fe•EDTA-
Jun 60mer (10 ).l.M). Lane 14, Fe•EDTA-Jun 60mer (10 ).l.M) and Fos(134-200) (20 
).l.M). Lane 15, Fe•EDTA-Jun 58mer (10 ).l.M). Lane 16, Fe•EDTA-Jun 58mer (10 
).l.M) and Fos(134-200) (20 ).l.M). Lane 17, Fe•EDTA Fos 67mer (10 ).l.M). Lane 18, 
Fe•EDTA-Fos 67mer (10 ).l.M) with Jun(212-280) (20 ).l.M). Lane 19, Fe•EDTA 
Fos 62mer (10 ).l.M). Lane 20, Fe•EDTA-Fos 62mer (10 ).l.M) with Jun(212-280) 
(20 ).l.M). Lane 21, Fe•EDTA Fos 57mer (10 ).l.M). Lane 22, Fe•EDTA-Fos 57mer 
(10 ).l.M) with Jun(212-280) (20 ).l.M). Lane 23, Fe•EDTA-GBR-FZIP (10 ).l.M). 
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tein, the 67mer, cleaved DNA specifically as a homodimer. Cleavage was 
most notable at the GCRE, with only faint cleavage at the ARE. In the 
presence of 20 J.lM Jun, a large increase in cleavage by the 67mer at the ARE 
was observed. In contrast, neither the 62mer nor the 57mer cleaved DNA 
specifically in the presence or absence of Jun. These results imply that the 
deletion of NH2-terminal segments inJun has a greater effect on the stability 
of the homodimer than the heterodimer, suggesting that those segments are 
necessary only in one half of the heterodimer. It is unclear why the deletions 
in Fos affect the stability of the homo- and heterodimers so dramatically. 
None of the deleted residues is analagous to those making contacts in the 
GCN4-DNA cocrystal structure,61 (Fig. 11) though the segment is highly basic. 
Cleavage by the chimeric GBR-FZIP 67mer is also shown in Figure 17 
(lanes 23, 24). At concentrations greater than 5 J..LM, it cleaves DNA as a 
homodimer. However, at a concentration of 10 J.lM, Fe•EDTA-GBR-FZIP 
cleaves much less efficiently than does Fe•EDTA-GCN4 at a concentration of 
5 J.lM (compare lanes 4 and 23). Because the basic regions are the same in the 
two homodimers, this indicates that the decreased specific DNA cleavage seen 
with the Fos proteins is in large part due to weak dimerization. Fe•EDTA-
GBR-FZIP also cleaves specifically in the presence of the Fos 67mer (data not 
shown) and more strongly in the presence of the Jun 69mer (lane 24), but not 
in the presence of GCN4, as expected. Interestingly, no polarity in the 
cleavage pattern is seen for the homodimer or for the Jun heterodimer, but 
the cleavage pattern for Fe•EDTA-GBR-FZIP + Fos appears to resemble that 
for Fe•EDTA-Jun + Fos, suggesting that Fos has a binding preference for the 
5'-ATGAC-3' half site at the GCRE. 
In crosslinking studies with Jun-Fos heterodimers at a 5'-CTGACTCAT-3' 
site (TRE), Fos formed crosslinks preferentially with a bromouridine at the 
76 
lR' position, while Jun formed crosslinks when a bromouridine was 
substituted at the lL' position (Fig. 9C).80 These results are in contrast to the 
polarity observed at the GCRE, in which Fos appeared to bind preferentially to 
the left half site, and to the lack of polarity observed at the ARE. Both the 
GCRE and the ARE differ from the optimal GCN4 and Jun-Fos binding site, 
the palindromic site 5'-ATGACTCAT-3'. The binding polarity of Jun-Fos 
heterodimers may therefore vary from sequence to sequence. While the TRE 
should allow all contacts seen in the GCN4 structure to be made, two bases at 
the GCRE and one base at the ARE that are involved in sequence-specific 
contacts are mutated.61 It is somewhat surprising that the GCRE is a stronger 
GCN4 and Jun-Fos binding site than the less severely altered ARE, suggesting 
that alternate contacts can be made. Thus, the degree of binding polarity at 
each site could be determined not only by the residues flanking the Arg (243 
in GCN4) making specific contacts at the central base pair,61 but also by the 
degree to which each monomer can rearrange structurally to accomodate 
particular mutations in the binding site. 
EXPERIMENTAL 
Materials. 
Protected amino-acid derivatives were purchased from Peninsula 
Laboratories or Applied Biosystems. Boc-L-His(DNP) was obtained from 
Fluka. Benzhydrylamine resin was obtained from U. S. Biochemical Corp. 
Arg-(Phenylacetamido)methyl (PAM) resin, N, N - dimethylformamide 
(DMF), diisopropylethylamine (OlEA), dicyclohexylcarbodiimide in 
dichloromethane, N- hydroxybenzotriazole (HOBt) in DMF, and 
trifluoroacetic acid (TFA) were purchased from Applied Biosystems. 
Dichloromethane and methanol (HPLC grade) were obtained from 
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Mallinckrodt, HOBt, p -cresol and p -thiocresol from Aldrich, and diethyl 
ether (low peroxide content) from Baker. 
Doubly distilled water was further purified through the Milli Q filtration 
system from Millipore. Sonicated, deproteinized calf thymus DNA was 
purchased from Pharmacia and dissolved in H20 to a concentration of 1 mM 
in base pairs. tRNA (E. coli strain W, Type XX) was obtained from Sigma 
and was dissolved in water and sterile-filtered. Enzymes were obtained from 
Boehringer-Mannheim or New England Biolabs and used with the buffers 
supplied. Deoxyadenosine- 5'- [a- 32p]-triphosphate and adenosine- 5'-[y _32p]-
triphosphate were obtained from Amersham. The plasmid pARE/GCRE was 
a generous gift from Keith Harshman and Prof. Carl Parker. 
UV-vis spectra were recorded on a Hewlett-Packard Diode Array 
spectrophotometer. Cerenkov radioactivity was measured with a Beckman LS 
3801 Scintillation Counter. Laser densitometry of gel autoradiograms was 
performed on a LKB Ultrascan XL densitometer. Manual peptide syntheses 
were carried out in 20 mL vessels fitted with coarse glass frits as described by 
Ken t. 1 5 Automated peptide syntheses were performed in a 20 mL 
Teflon/KelP reaction vessel on an ABI 430A peptide synthesizer modified by 
the removal of the in-line filters to the top and bottom of the reaction vessel. 
Coordinates for the GCN4-DNA cocrystal structure were generously provided 
by Dr. T. E. Ellenberger and Prof. S.C. Harrison. 
Methods. 
Peptide Syntheses. All peptide syntheses were carried out using stepwise 
solid phase methods with N-a-Boc L-amino acids.15 All four unmodified 
GCN4 peptides were made from a single manual synthesis starting with an 
Arg-PAM resin. 14,16 The average yield over 59 amino acid couplings in the 
synthesis of GCN4(222-281) was 99.4% as determined by Ninhydrin analysis.83 
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All three unmodified Fos peptides were synthesized from a single peptide 
synthesis from a BHA resin.14,16 The average yield over 67 amino acid 
couplings in the synthesis of Fos(134-200) was 99.7%. The first synthesis of 
three unmodified Jun peptides was performed in a single automated 
synthesis from BHA resin14,16 on an ABI 430A peptide synthesizer using 
protocols developed at the California Institute of Technology.15 The average 
coupling yield for the synthesis of Jun(212-280) was 99.2%, with individual 
yields as low as 93.4%. The second set of unmodified Jun proteins was carried 
out as a single manual synthesis from BHA resin with an average yield per 
coupling of 99.6%. The chimeric protein GBR-FZIP 67mer was prepared from 
resin-bound Fos(165-200) (taken from the same synthesis described above) in 
an automated synthesis with an average coupling yield of 99.7%. 
y-Aminobutyric acid (GABA) and EDTA, protected as the tricyclohexyl 
ester13, were coupled to the NH2-terminus of each peptide. All peptides were 
deprotected with anhydrous HF and purified by reverse phase HPLC (C4 or 
C8).14,16 All were single peaks by analytical RP-HPLC (C8) except in the case of 
the first Jun synthesis. 
DNA Binding and Cleaving Assays. All assays were performed on a 32p_ 
end-labelled restriction fragment (EcoRI-Pvu II) from the plasmid 
pARE/GCRE,66 which was prepared by standard procedures.84 A-specific 
sequencing reactions were performed according to Iverson and Dervan.85 
DNase I footprinting1 reaction conditions were 10 mM Tris•HCl, 10 mM 
KCI, 10 mM MgC12, 5 mM CaC12, 200 ~M dithiothreitol (DTT), 0.33 ~g/mL 
DNase I, 200 ~M calf thymus DNA (bp), and 30,000 cpm end-labelled DNA, 
pH 7.0. Reactions were initiated with the addition of DNase and DTT, then 
allowed to proceed at room temperature for 3.5 minutes. MPE footprinting2,3 
reaction conditions were 20 mM phosphate, 20 mM NaCl, 5 mM DTT, 100 ~M 
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calf thymus DNA and 30,000 cpm labelled DNA, pH 7.5. Reactions were 
initiated with the addition of MPE • Fe(II) and OTT, then allowed to proceed at 
room temperature for 10 minutes. Affinity cleaving reaction conditions were 
30rnM Tris•HCl, 3mM sodium acetate, 20 mM NaCl, 5 mM OTT, 100 J..l.M calf 
thymus DNA and 20,000 cpm labelled DNA, pH 7.9. Reactions were initiated 
with the addition of OTT, then allowed to proceed at room temperature for 30 
minutes. For all types of reactions, the peptides and the DNA were allowed to 
equilibrate for 30 minutes at room temperature before the reactions were 
initiated. For heterodimer experiments, proteins were allowed to equilibrate 
for one hour at 37° before ON A was added. 
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CHAPTER THREE 
EVIDENCE THAT A DESIGNED SYNTHETIC PEPTIDE AND A 
DNA-BINDING PROTEIN CAN SIMULTANEOUSLY OCCUPY A 
COMMON BINDING SITE ON DOUBLE -HELICAL DNA 
GCN4 is a yeast transcriptional activator responsible for the coordinate 
induction of 30 - 50 genes involved in amino acid biosynthesis in response to 
amino acid starvation.1 This protein is a member of a class of sequence-specific 
DNA-binding proteins known as the leucine zipper-basic region proteins, which 
are proposed to bind to ON A through a conserved structural motif consisting of 
a coiled coil dimerization domain, often termed the leucine zipper, and a DNA-
binding domain termed the basic region.2-13 These proteins recognize, as 
dimers, binding sites on DNA consisting of abutted inverted repeats. For GCN4, 
the consensus DNA binding site is 5'-rrTGACTcatt-3', where the underlined C 
corresponds to the center ofpseudodyad symmetry.l4,15 
The C-terminal 60 amino acids of GCN4 (residues 222-281) contain both the 
leucine zipper and basic regions and have been shown to be necessary and 
sufficient for both dimerization and sequence-specific DNA binding.J6,17 Two 
detailed modeling studies of leucine zipper-basic region proteins have been 
reported: the scissors-grip model of Vinson et al.13 and the induced helical fork 
model of O'Neil et al.lO Although these structural models differ slightly, both 
propose exclusively major groove binding. Footprinting, methylation 
interference, and ethylation interference studies are also consistent with largely 
major groove binding by these proteins.13,18,19 Affinity cleaving proteins based 
on the DNA-binding domain of GCN4 with the DNA cleaving moiety Fe• EDTA 
at the NH2-terminus have been synthesized (Fig 1, A and B).20 Cleavage 
patterns generated by Fe•EDTA-GCN4(226-281) bound to the DNA sites 5'-
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CTGACTAAT-3' and 5'-ATGACTCTI-3' reveal that the NH2-termini of the 
GCN4 DNA binding domain are located in the major groove of DNA, nine to ten 
base pairs apart, consistent with a Y-shaped dimeric structure.20 However, at 
the time this work was published, the structure of the DNA binding region of 
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Figure 1. (A) The sequence of the carboxy terminal 56 amino acids (226-281) of 
GCN4. The sequence is shown from the NH2-terminus of the peptide to its 
C02H-terminus. (B) Synthetic peptide EDTA-GCN4(226-281). (C) Synthetic 
minor groove binding peptide 2-ImN. 
1-Methylimidazole-2-carboxamide-netropsin (2- ImN) is a synthetic analog 
of the naturally occurring minor groove binding peptide distamycin A, wherein 
the NH2-terminal pyrrole has been replaced by 1-methylimidazole in order to 
allow for the binding of sites containing G, C base pairs (Figure lC). 
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Footprinting and affinity cleaving studies reveal that 2-ImN binds to the five 
base pair sequence 5'- TGACT -3·,22 the conserved element of the GCN4 
recognition site. Two-dimensional NMR studies have recently shown that 2-
lmN binds to its recognition site in the minor groove of DNA as a side-by-side, 
antiparallel dimer,23 forming a complex similar to that observed for distamycin 
















Figure 2. Schematic models for (A) the binding of the 2-ImN antiparallel dimer in 
the minor groove of DNA in which 2-ImN monomers are represented as arrows, 
(B) the leucine zipper DNA-binding motif in which the leucine zipper domains 
are represented by a pair of cylinders pointing into the DNA, and (C) both 
dimers binding to the same DNA molecule. 
The complexes formed by 2-ImN and the GCN4 DNA binding domain with 
their common DNA binding site are shown schematically in Figures 2A and 2B, 
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respectively. The question arises as to whether these molecules can bind to their 
common DNA binding site simultaneously (Fig. 2C). This question of mutual 
recognition is addressed here by the use of Fe•EDTA-GCN4(226-281) as a 
sequence-specific footprinting reagent. Following chemical activation with a 
reducing agent such as dithiothreitol (DTT), Fe•EDTA localized in the major 
groove at a specific DNA binding site cleaves the proximal and distal strands of 
the adjacent minor grooves via a diffusible, non-sequence-specific radical, most 
likely hydroxyl20,25-27. The cleavage pattern generated by the dimeric 
Fe•EDTA-GCN4(226-281) extends beyond the five base pair recognition site for 
2-ImN. Therefore, the peptide dimer bound in the minor groove should be 
capable of protecting its binding site from cleavage by diffusible radicals 
generated locally by Fe•EDTA-GCN4(226-281) bound at the same sequence in 
the major groove. This protection will be observed if, and only if, the major 
groove binding protein GCN4 and the minor groove binding synthetic peptide 2-
IrnN share their sites simultaneously on the same molecule of DNA. 
RESULTS AND DISCUSSION 
Simultaneous Binding of 2-ImN and GCN4. Footprinting and affinity cleaving 
assays were performed on a restriction fragment (Eco RI -Pvu II) from the 
plasmid pARE/GCRE,28 which was separately 5'- and 3'-32P-end-labeled at the 
Eco RI site. This DNA fragment contains two binding sites for GCN4 and 2-IrnN, 
5'-CTGACTAAT-3' and 5'-ATGACTCTT-3', previously designated ARE and 
GCRE, respectively.28 The DNA cleavage products were separated by 
polyacrylamide gel electrophoresis and visualized by autoradiography (Fig. 3). 
From MPE•Fe footprinting, 2-ImN protects a region of approximately five 
base pairs at the site 5'-TGACT-3' (Fig. 3, lanes 7 and 8, Fig. 4B), consistent with 
previous footprinting and affinity cleaving data22 and direct NMR studies.23 
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Figure 3. Autoradiogram of a high resolution denaturing polyacrylamide gel of 
2-IrnN and GCN4(226-281) footprinting and of Fe•EDTA-GCN4(226-281) affinity 
cleaving reactions in the presence and absence of 2-IrnN. Odd numbered lanes 
are 5'-end-labeled and even numbered lanes are 3'-end-labeled. Lanes 1 and 2, 
DNA control lanes; lanes 3 and 4, A-specific chemical sequencing lanes; lanes 5 
and 6, MPE•Fe control lanes; lanes 7 and 8, MPE•Fe cleavage protection by 
GCN4(226-281) (5 J..LM); lanes 9 and 10, MPE•Fe cleavage protection by 2-ImN 
(50 J..LM); lanes 11 and 12, Fe•EDTA-GCN4(226-281) at 5 J..LM; lanes 13 and 14, 
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Figure 4. The sequence from left to right represents the data between the 
markers on the left-hand side of the gel shown in Fig. 3. (A) Bars represent the 
extent of protection from MPE • Fe cleavage at the ARE and GCRE sites in the 
presence of 5 J.!.M GCN4(226-281) (Fig. 3, lanes 7 and 8). (B) Bars represent the 
extent of protection from MPE•Fe cleavage at the ARE and GCRE sites in the 
presence of 2-ImN (50 J.!.M); boxes denote 2-ImN binding sites (Fig. 3, lanes 9 and 
10). (C) Arrows represent the extent of cleavage at the ARE and GCRE sites for 
Fe• EDTA-GCN4(226-281) at 5 J.!.M (Fig. 3, lanes 11 and 12). (D) Arrows 
represent the extent of cleavage at the ARE and GCRE sites for Fe•EDTA-
GCN4(226-281) at 5 J.!.M in the presence of 2-ImN (50 J.!.M); boxes denote 2-ImN 
binding sites (Fig. 3, lanes 13 and 14). 
A . MPE•Fe Footprint of GCN4(226-281) 
B. MPE•Fe Footprint of 2-lmN 
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GATCCTCTAGAGTCGACCAGATCT 
C TAG GAGATCTC AGCTGGTCTAGA 
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C. Cleavage by Fe•EDTA-GCN4(226-281) 
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GCN4(226-281) protects an 18 bp region which contains the same five base pair 
site, 5'-TGACT-3'. Importantly, the products of cleavage by Fe•EDTA-
GCN4(226-281) in the absence and in the presence of 2- ImN differ (Fig. 3, lanes 
11 -14, Fig. 4C,D). The tripartite cleavage pattern for Fe•EDTA-GCN4(226-281) 
results from cleavage of the DNA binding site by two Fe•EDTA moieties 
localized in successive major grooves (Fig. 6A).20 The cleavage pattern extends 
well beyond the five base pair binding site for 2- ImN in both directions. 
Comparisons of lane 11 with lane 13 and lane 12 with lane 14 demonstrate that 
the intensity of cleavage is reduced dramatically in the central region of the 
cleavage pattern in the presence of 2- ImN. This cleavage pattern is unaltered 
upon changing the order of addition of the two DNA-binding molecules (data 
not shown). The histograms in Figures 4C and D and the densitometry traces in 
Figure 5 compare the cleavage patterns observed in the presence and absence of 
2-lmN. The base positions at which cleavage intensity is reduced correspond to 
those bases protected by 2-lmN from cleavage by MPE•Fe, demonstrating that 2-
c 
T 
5'- 32P-labelled DNA 
Fe•EDTA GCN4 (226-281) 





3'- 32P-labelled DNA 
Figure 5. Phosphor storage densitometry traces of the 5'-TGACT-3' sequence 
from the lower binding site (ARE) in lanes 11-14 of Figure 3. The solid lines 
show the data obtained from cleavage of the DNA with Fe•EDTA-GCN4(226-
281) in the absence of 2-ImN; the dashed lines show the data obtained in the 
presence of 2-ImN. The peaks corresponding to the sequence 5'-TGACT-3' are 
indicated. 
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ImN is capable of binding in the presence of Fe•EDTA-GCN4(226-281). 
It is important to note that the cleavage pattern observed in Figure 4D can 
only occur if the two molecules occupy their common binding site simultaneously. 
If binding by 2-ImN in the minor groove prevents Fe•EDTA-GCN4(226-281) 
from binding, no specific cleavage will be observed. Similarly, if binding by 
Fe•EDTA-GCN4(226-281) in the major groove prevents 2-ImN from binding in 
the minor groove, an unaltered cleavage pattern will be observed (Fig. 3D). 
Furthermore, the cleavage intensity in the upper and lower sections of the 
tripartite Fe•EDTA-GCN4(226-281) cleavage pattern, which do not overlap a 
TGACT sequence, serves as an internal control for a decrease in the binding 
affinity of Fe•EDTA-GCN4(226-281) in the presence of 2-lmN. As can be seen 
from the data (Figure 3; Figure 4C and D), these bands are of similar intensity in 
the presence and absence of 2- ImN. The cleavage pattern for Fe•EDTA-
GCN4(226-281) in the presence and absence of 2-ImN is shown mapped to a 
DNA double helix in Figure 6. 
DNA Structure. This example of simultaneous sequence-specific 
complexation of a shared DNA binding site by a protein and a small molecule is 
in contrast to results seen with related systems. The minor groove binder 
distamycin inhibits cleavage by restriction endonucleases29 and topoisomerase 
n30 at A,T-rich sites. In addition, distamycin has been shown to inhibit the 
binding of regulatory proteins such as OTF-1, NFE-131 and the homeodomain 
proteins Ftz and Antp.32 Surprisingly, distamycin is able to disrupt binding of a 
Ftz homeodomain peptide lacking the NH2-terminal arm involved in minor 
groove specific contacts, implying that direct competition for the minor groove 
binding site is not required for inhibition. 32 It is proposed that the protein 
binding affinity is also reduced by a distamycin-induced conformational change 










Figure 6. (A) Schematic forB-form DNA indicating the most intense cleavage 
sites for Fe•EDTA-GCN4(226-281) at the GCRE site. Filled circles represent the 
points of cleavage along the phosphodiester backbone. (B) A map of the most 
intense cleavage sites for Fe• EDTA-GCN4(226-281) in the presence of 2-ImN. 
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It is of interest to understand how the DNA is able to accommodate 
structurally the two dimeric species, GCN4 and 2-ImN. The simplest assumption 
is that different faces of the same local DNA structure are recognized by both 
dimers. Although some members of the leucine zipper-basic region class of 
DNA-binding proteins have been shown to bend their DNA recognition sites 
either toward (Jun-Jun homodimers) or away from (Jun-Fos heterodimers) the 
m inor groove,33,34 similar studies with GCN4 gave no evidence of protein-
induced DNA bending.18 Similarly, NMR studies with 2-ImN are consistent 
w ith no major d istortion of the DNA double helix as a result of ligand binding.23 
Table I. Binding constants for 2-ImN at two DNA binding sites measured 
by footprint titrations using Fe•EDTA-GCN4(226-281) and MPE•Fe. 







2.2 (0.3) X 105 
1.5 (0.4) X 105 
2.3 (0.6) X 105 
2.2 (0.5) X 105 
a Values reported are the mean values measured from three or four foot-
print titration experiments. Numbers in parentheses indicate the standard 
deviation for the data set.b The assays were performed at room tempera-
ture, pH 7.9, in the presence of 30 mM tris-hydrochloride, 3 mM sodium 
acetate, 20 mM sodium chloride. 
Nevertheless, modeling studies indicate that the minor groove width in the 
2-ImN•5'-TGACT-3' complex may be larger than that observed for canonical B-
form DNA in order to accommodate the 2-lmN dimer.23 If even modest 
structural changes are induced upon binding of either the GCN4 or the 2-ImN 
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Figure 7. Data for the MPE•Fe and Fe•EDTA-GCN4(226-281) quantitative 
footprinting experiments at (A) the ARE site and (B) the GCRE site. The 
sigmoidal curves show the titration binding isotherms plotted with eq 2 using 
Omin = 0, Bmax = 1, and the mean Ka value for each set (Table I). The solid curves 
represent the MPE•Fe footprinting data, the dotted curves, the Fe•EDTA-
GCN4(226-281) data. The data points are taken from the average of the 
normalized Oapp values at each concentration of 2-ImN; filled circles correspond 
to MPE•Fe data, open diamonds to Fe•EDTA-GCN4(226-281) data. 
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Figure 8. Gray-scale representation of a storage phosphor autoradiogram of a 
denaturing 8% polyacrylamide gel showing quantitative MPE footprinting 
titration reactions for 2-lmN. All lanes except the sequencing lane contain s•32p_ 
end-labeled DNA. Lane 1, intact DNA; lane 2, 3'-A-specific sequencing 
reaction; lane 3, MPE control lane; lanes 4-18 show MPE cleavage protection by 2-
ImN at concentrations of 100, 75, 50, 35, 10, 7.5, 5, 3.5, 2, 1, 0.75, 0.5, 0.35, 0.2, and 
0.1 J,.LM, respectively. 
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Figure 9. Gray-scale representation of a storage phosphor autoradiogram of a 
denaturing 8% polyacrylamide gel showing quantitative EDTA-GCN4(226-281) 
footprinting titration reactions for 2-IrnN. All lanes except the sequencing lane 
contain s·-32P-end-labeled DNA. Lane 1, intact DNA; lane 2, 3'-A-specific 
sequencing reaction; lane 3, EDTA-GCN4(226-281) control lane; lanes 4-18 show 
EDTA-GCN4(226-281) cleavage protection by 2-IrnN at concentrations of 100, 75, 
50, 35, 10, 7.5, 5, 3.5, 2, 1, 0.75, 0.5, 0.35, 0.2, and 0.1 ~,respectively. 
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expected. In order to address this possibility, we have measured the binding 
affinity constants for 2-ImN in the presence and in the absence of Fe•EDTA-
GCN4(226-281). To measure the apparent association constant of 2-ImN for each 
site in the absence of Fe•EDTA-GCN4(226-281), we used a quantitative MPE•Fe 
footprint titration procedure,35 adapted from the quantitative DNase footprint 
titration procedure of Ackers and co-workers.36 A typical MPE gel is shown in 
Figure 8. To measure the apparent association constant for each binding site in 
the presence of Fe•EDTA-GCN4(226-281), we used the protein itself as a site-
specific footprinting agent; a typical Fe•EDTA-GCN4(226-281) gel is shown in 
Figure 9. 
Because NMR23 and affinity cleaving22 experiments support the 
assumption of ali-or-none binding, apparent fractional saturation values (8app, eq 
1) were fit to a modified Hill equation (eq 2).37,38 The means of the best-fit 
apparent monomeric association constants are listed in Table I; the 
corresponding binding isotherms are shown in Figure 7. The association 
constants for 2-ImN in the presence and absence of Fe•EDTA-GCN4(226-281) 
differ by less than a factor of two at both sites and probably are not different 
within the error of the experiment. These data indicate that there is little, if any, 
cooperativity between the two molecules, supporting a model in which neither 
the 2-ImN dimer nor the truncated GCN4 dimer perturbs the common DNA 
binding site significantly. 
CONCLUSION 
The DNA-binding domain of the leucine zipper-basic region protein GCN4 
and the synthetic minor groove-binding peptide 2-ImN can bind to their 
common DNA binding site simultaneously. This result supports models in 
which leucine zipper-basic region proteins bind to their DNA binding sites 
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exclusively in the major groove, leaving the minor groove unoccupied. 
Furthermore, binding of Fe•EDTA-GCN4(226-281) in the major groove has little 
or no effect on the equilibrium binding constant for 2-ImN. This demonstration 
that both grooves of the DNA may be occupied without significantly weakening 
the binding affinity of the major or minor groove binding molecules suggests that 
tight-binding synthetic molecules may be designed with components interacting 
with both grooves of DNA over a limited sequence space. 
EXTENSION TO OTHER SYSTEMS 
]un and Fos Homodimers and Heterodimers. Preliminary investigations were 
undertaken to examine the effect of 2-ImN binding on Jun-Jun and Fos-Fos 
homodimers, as well as Jun-Fos heterodimers. Unlike GCN4, Jun-Jun 
homodimers and Jun-Fos heterodimers have been shown to bend their DNA 
recognition sites.33,34 Because Jun-Jun homodimers and Jun-Fos heterodimers 
bend DNA in opposite directions,33,34 it was of interest to determine whether 
the two dimers exhibited different behavior in the presence of a minor groove 
binder at the same DNA sequence. Qualitative experiments indicated that 2-ImN 
can protect its binding site from cleavage by Fe•EDTA-derivatives of Jun-Jun 
homodimers, Fos-Fos homodimers, and Jun-Fos heterodimers (data not shown; 
MGO III-151). The Jun-Fos homodimers would be expected to widen the minor 
groove, allowing 2-ImN to bind. However, Jun-Jun homodimers bend DNA 
toward the minor groove and would be expected to have an inhibitory effect on 
2-ImN binding. No such effect was observed. It is known that truncated Jun and 
Fos proteins such as those used in these experiments bend DNA to a lesser 
degree than the full proteins,33,34 and this bending may not be significant 
enough to affect 2-ImN binding. Alternatively, the Jun and Jun-Fos dimers may 
bend DNA outside the optimal 2-ImN binding site of 5'-TGACT-3'. Quantitative 
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footprinting titrations might reveal small effects not seen in qualitative 
experiments. 
Triple Helices. Michelle Parks performed experiments to determine whether 
or not the minor groove binders 2-ImN and distamycin could complex their 
DNA binding sites in a pyrimidine motif triple helix. 39 Optimal conditions for 
binding of a third strand to form a triple helix,27 especially the inclusion of 
spermine in the reaction mixture, were found to reduce the binding efficiency of 
the minor groove binders such that very high concentrations of these molecules 
were required.39 Under conditions in which quantitative footprinting and 
affinity cleaving titrations indicate that both the third strand and the minor 
groove binder should bind their sites, even in the presence of high concentrations 
of the other species, neither 2-ImN nor distamycin protected its binding site from 
cleavage by a pyrimidine-rich oligonucleotide complexed with Fe•EDTA.39 
Although the cleavage seen by pyrimidine triple helices does spill over into the 
adjacent minor grooves, generating the cleavage pattern shown in Chapter Two 
(Fig. 2),27 the percentage of cleavage in the minor groove is much less than for 
Fe•EDTA-GCN4(226-281),40 rendering a small reduction in the cleavage 
intensity more difficult to detect. 
The crystal structure of GCN4 provides an explanation for the largely minor 
groove cleavage effected by Fe•EDTA-GCN4(226-281).41 Asp-226, the residue to 
which Fe• EDT A is attached, is located three a-helical turns away from the amino 
acid residues making contacts with the DNA bases (approximately 13A from the 
nearest phosphate group).41 The generation of diffusible oxidant from an 
Fe• EDT A moiety held away from the DNA helix allows more even access to the 
major and minor grooves than would an Fe• EDT A moiety held close to the DNA 
in the major groove. Because GCN4 binds exclusively in the major groove, 
protecting it from cleavage, cleavage occurs largely from the minor grooves. 
MATERIALS AND METHODS 
Materials 
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Protected amino-acid derivatives were purchased from Peninsula 
Laboratories; Boc-L-His(DNP) was obtained from Fluka. Arg-
(Phenylacetamido)methyl (PAM) resin, N, N - dimethylformamide (DMF), 
diisopropylethylamine, dicyclohexylcarbodiimide in dichloromethane, N-
hydroxybenzotriazole (HOBt) in DMF, and trifluoroacetic acid (TFA) were 
purchased from Applied Biosystems. Dichloromethane and methanol (HPLC 
grade) were obtained from Mallinckrodt, HOBt, p -cresol and p -thiocresol from 
Aldrich, and diethyl ether (low peroxide content) from Baker. Mass 
spectrometry was performed at the New York University Electrospray Mass 
Spectrometry Regional Center by Dr. Steven Wilson and colleagues. 
Doubly distilled water was further purified through the Milli Q filtration 
system from Millipore. Sonicated, deproteinized calf thymus DNA was 
purchased from Pharmacia and dissolved in H20 to a concentration of 1 mM in 
base pairs. tRNA (E. coli strain W, Type XX) was obtained from Sigma and was 
dissolved in water and sterile-filtered. Enzymes were obtained from Boehringer-
Mannheim or New England Biolabs and used with the buffers supplied. 
Glycogen was obtained from Boehringer-Mannheim. Deoxyadenosine- 5'- [a-
32p]-triphosphate and adenosine- 5'-[y _32p]-triphosphate were obtained from 
Amersham. UV-vis spectra were recorded on a Hewlett-Packard Diode Array 
spectrophotometer. Cerenkov radioactivity was measured with a Beckman LS 
3801 Scintillation Counter. Storage phosphor technology autoradiography was 
accomplished using a Molecular Dynamics 400S Phosphorimager and 
ImageQuant software. Storage phosphor screens (Kodak #S0230) were 
purchased from Molecular Dynamics. 
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Methods 
Peptide and Protein Syntheses. EDTA-GCN4(226-281) and GCN4(226-281) 
were synthesized, deprotected and purified as previously described (Chapter 
Two, same synthesis).20,42-45 NH2-terminal sequencing of the purified 
GCN4(226-281) protein confirmed the desired sequence. Molecular masses were 
verified by electrospray mass spectrometry [GCN4(226-281): calculated mass, 
6615.7, observed, 6615.1; EDTA-GCN4(226-281): calculated mass, 6975.0, Na 
complex, 6998.0, Fe complex, 7030.9; observed 6998.2, 7031 .7]. 2-ImN was 
prepared and purified as previously described.22 Fe•EDTA-GCN4(226-281) was 
generated immediately prior to use by equilibration of 1 mM EDTA-GCN4(226-
281) with an equal volume of 1 mM ferrous ammonium sulfate for approximately 
10 min. Fe•EDTA-GCN4(226-281) was then diluted to a concentration of 25 J.l.M. 
DNA Manipulations. The 270 bp Pvu II -Eco RI restriction fragment of the 
plasmid pARE/GCRE28 was isolated and labeled at the 5'-or 3'- end by standard 
procedures.46 Chemical sequencing adenine-specific reactions were carried out · 
as previously described.47 MPE•Fe reaction conditions were 20 mM phosphate, 
20 mM NaCl, 5 mM DTT, 5 ~M MPE•Fe, 100 ~M calf thymus DNA, and 20,000 
cpm labeled DNA, pH 7.5. The DNA binding molecules were allowed to 
equilibrate with the DNA for 30 min. Reactions were then initiated by the 
addition of MPE • Fe, followed immediately by DTT, and allowed to proceed 10 
min at room temperature. Affinity cleaving reaction conditions were 30 mM 
Tris•HCl, 3 mM sodium acetate, 20 mM NaCl, 5 mM DTT, 100 ~M calf thymus 
DNA, and 20,000 cpm labeled DNA, pH 7.9. 2- ImN was allowed to equilibrate 
with the DNA at room temperature for 30 min, at which point Fe•EDTA-
GCN4(226-281) was added and allowed to equilibrate with the DNA for a 
further 30 min. The reactions were initiated with the addition of DTT and 
allowed to proceed at room temperature for 30 min. All reactions were 
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terminated by ethanol precipitation; the residues were dried and resuspended in 
100 mM tris-borate-EDTA/80% formamide loading buffer. Reaction products 
were analyzed by electrophoresis on 8% polyacrylamide denaturing gels (5% 
crosslink, 7M urea) . After electrophoresis, gels were dried and 
autoradiographed. Gels were analyzed using storage phosphor technology. 
Storage phosphor screens were pressed against dried gels and exposed. A 
Molecular Dynamics 400S Phosphorlmager was used to obtain data from storage 
screens, and data were analyzed by performing area integrations along lines 
drawn down the center of each lane using the ImageQuant v.3.0 software 
running on an AST Premium 386/33 computer. 
Quantitative Footprint Titrations. The above reaction conditions were 
modified for quantitative footprinting as follows. tRNA was used in place of calf 
thymus DNA in order to minimize the binding of 2-ImN to carrier nucleic acid. 
Stock solutions of 2-lmN were diluted serially to give 15 solutions of 
concentrations ranging from 500 nM to 500 J.lM, leading to final reaction 
concentrations of 100 nM to 100 J.lM. Final reaction conditions were 30 mM 
Tris•HCl, 3 mM sodium acetate, 20 mM NaCl, 2 mM DTT, 100 J.lg/mL tRNA, 5 
J.lM Fe•EDTA-GCN4(226-281) or 2.5 J.lM MPE•Fe, and 20,000 cpm 5'-32p end-
labeled DNA, pH 7.9. For MPE•Fe footprinting, 2-ImN was allowed to 
equilibrate at room temperature with the DNA for 1 h, followed by the addition 
of MPE•Fe and DTT. Reactions were quenched by ethanol precipitation after 30 
min. For Fe•EDTA-GCN4(226-281) footprinting, 2-ImN was allowed to 
equilibrate with the DNA at room temperature for 45 min, followed by the 
addition of Fe•EDTA-GCN4(226-281). After 45 min, the reactions were initiated 
with DTT. Reactions were quenched by ethanol precipitation after a further 30 
min. 
108 
Footprint Titration Fitting Procedure. The footprint titration gels were 
quantitated using storage phosphor technology, and data were analyzed by 
performing volume integrations of the target and reference sites using the 
ImageQuant v.3.0 software running on an AST Premium 386/33 computer. The 
target sites chosen were the two 5'-TGACT -3' sites found in the restriction 
fragment. For the MPE•Fe footprint titrations, reference sites were chosen at 
which little 2-Irn.N binding was observed even at the highest concentrations, 
generally G, C-rich sites. For the Fe•EDTA-GCN4(226-281) footprint titration 
experiments, reference sites were taken from regions at each Fe • EDT A-
GCN4(226-281) cleavage site at which the intensity of cleavage was unaltered. 
Specifically, the lower set of cleavage bands at each site was used: 5'-GGTT-3' at 
the ARE site, and approximately 5'-TAAAAA-3' at the GCRE site. 
The data from MPE•Fe and Fe•EDTA-GCN4(226-281) footprint titrations 
were analyzed using a method analogous to that described for analysis of DNase 
I footprint titrations.22,36 The apparent DNA target site saturation, Bapp' was 
calculated using the following equation: 
(1) 
where ltot and Iref are the integrated volumes of the target and reference sites, 
respectively, and ltot0 and Iret correspond to those values for an MPE•Fe or 
Fe•EDTA-GCN4(226-281) control lane to which no 2-ImN has been added. The 
([LltotJ Bapp) data points were fit by minimizing the difference between Bapp and 
8fit, using the modified Hill equation: 
Ka2[L]to? 
1 + Ka 2[L]tot2 (2) 
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where [Lltot corresponds to the total 2-lmN concentration, Ka corresponds to the 
apparent monomeric association constant, and Omin and Omax represent the 
experimentally determined site saturation values when the site is unoccupied or 
saturated, respectively. 
Data were fit using a nonlinear least-squares fitting procedure of 
KaleidaGraph software (version 2.1, Abelbeck software) running on a Macintosh 
llfx computer with Ka, Omax, and Omin as the adjustable parameters. All lanes 
from each gel were used unless visual inspection of the computer image from a 
storage phosphor screen revealed a flaw at the target or reference site, or the Oapp 
value was greater than two standard errors away from values in both 
neighboring lanes and greater than two standard errors from the initial Ofit· Data 
for experiments in which fewer than 80% of the lanes were usable were 
discarded. The data were normalized using the following equation: 
0app- 0min 
0max- 0min (3) 
The uncertainty in Onorm was estimated from the scatter in the normalized data 
for the four lowest and four highest concentrations of 2-lmN. A standard 
uncertainty in Onorm of 0.07 was used in a x2 analysis of normalized data, with x2 
~ 1.0 as the criterion for an acceptable fit. Three or four sets of acceptable data 
were used in determining each association constant. 
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CHAPTER FOUR 
DESIGN OF A HYBRID PROTEIN CONTAINING THE 
DNA-BINDING DOMAIN OF HIN RECOMBINASE AND THE 
IRON-BINDING LIGAND OF BLEOMYCIN 
Bleomycin. 
The bleomycins (BLMs, Fig. 1) are a group of glycopeptide antibiotics 
with clinically useful antitumor activities.1 Bleomycin has been shown to 
cleave double-stranded DNA efficiently and specifically in the presence of 
oxygen and certain metal ions, most notably Fe(II) (for reviews, see references 
2-4). Oxidative cleavage occurs primarily at a subset of 5'-GC-3' and 5'-GT-3' 
sites5,6 and results from degradation of the deoxyribose backbone of the 3' 
nucleotide of each site by an activated Fe•Bleomycin species, leading to a 
single strand break at each DNA binding site?-9 
Figure 1. Bleomycin A2. 
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Mechanism. An activated iron-bleomycin complex competent to cleave 
DNA may be formed from bleomycin in the presence of: Fe(II) and 02; Fe(II), 
02, and a reducing agent, such as DTT or 13-mercaptoethanol; Fe(III) and 
hydrogen peroxide;9 or Fe(III) and single oxygen donors such as iodosyl 
benzene or oxone.10 A proposed mechanism for the generation of "activated 
bleomycin" is shown in Figure 1.9 Upon addition of oxygen to Fe(II)•BLM, a 
ternary complex is formed which must undergo one electron reduction in 
order to form "activated bleomycin," a complex distinguishable from its 
precursors by the appearance of an EPR spectrum.9 If no external reductant 
has been added, Fe(II) or Fe(II) • BLM can function as an electron source.11, 12 
"Activated bleomycin" may also be formed from Fe(III) and H202 in the 
absence of 02. Although the structure of "activated bleomycin" remains 
controversial, it is known to have two more oxidizing equivalents than 
Fe(III) • BLM, 13 and the similarity between the spectral data for BLM and the 
iron-porphyrins has led some investigators to propose the intermediacy of a 
high-valent iron-oxo species in the degradation of DNA by BLM)O 
Fe(ll) + BLM ---- Fe(II)•BLM ~ Fe(II)•BLM•O 2 ~-
---~~ "activated bleomycin" ~ Fe(III)•BLM 
H202 ( 
Fe(III) + BLM ---~ Fe(III)•BLM 
Figure 2. Proposed mechanism for the formation of "activated bleomycin." 
Adapted from reference 9. 
The activated bleomycin complex initiates DNA cleavage by abstraction 
of the C-4'-hydrogen of the deoxyribose backbone, as shown by primary 
tritium and deuterium isotope effects at the 4'-position?,8,14 This leads to 


























































































































































































































































































































































ratio of these two sets of products is dependent on oxygen concentration.2-4 
The release of base propenals requires an additional equivalent of 
oxygen; a proposed mechanism for this oxygen-dependent production of base 
propenals from the 4'-deoxyribose radical intermediate is shown in Figure 3. 
The additional equivalent of 02 leads to a 4'-hydroperoxide species which is 
thought to undergo a Crieggee rearrangement in which the Fe•BLM complex 
acts as a Lewis acid catalyst.15 It was originally proposed that the resulting 
carbocation was trapped by H20 or by the BLM • FeOH species resulting from 
the Fe•BLM catalysis of the Creigee rearrangement (Figure 3, pathway A).2,16 
However, this pathway is inconsistent with more recent 18Q labeling 
studies.17 The oxygens in the 3'-phosphoglycolate moiety are derived from 
02 and from the 04' of the original deoxyribose species. In addition, the 
oxygen of the base propenal is derived exclusively from water. A mechanism 
consistent with the results has been proposed (Fig. 3, pathway B).17 In this 
model, abstraction of the 2'-pro-R-proton 17 with concomitant anti-
elimination of 04'-occurs immediately following the Criegee rearrangement. 
The order in which the 5'-phosphate and 3'-phosphoglycolate moieties are 
eliminated is unclear (Fig. 3, pathways B-1 and B-2). However, in both 
models, the first elimination reaction is base-assisted and yields a conjugated 
species that can undergo Michael addition of water to form a reactive 
hemiacetal. This species then undergoes decomposition to the base propenal 
and 5'-phosphate or 3'-phosphoglycolate. No further studies to test this 
model have been reported. 
The pathway for the formation of free base and an alkali-labile lesion has 
also been investigated extensively; a proposed mechanism is shown in Figure 
4. The 4'-hydroxylated intermediate18 is thought to form by electron transfer 

























































































































































































































vent.19 The alternative proposal of a "radical rebound" mechanism in which 
bleomycin catalyzes a recombination between the carbon-centered radical 
and hydroxyl radical is inconsistent with oxygen labeling experiments.J9,20 
This intermediate then decomposes, leading to the release of free base and to 
an alkali-labile species that has been identified by trapping with sodium 
borohydride.21 Upon treatment with base, this lesion is degraded further, 
resulting in the release of 5'-phosphate and the two 3'-products, phosphate 
and the cyclopentenone product shown in Figure 4. The identity of these 
products has been confirmed by HPLC analysis against authentic standards.22 
When butylamine is used instead of hydroxide in the base treatment, 3'- and 
5'-phosphates are produced exclusively.22 
Bleomycin Structure. Bleomycin has traditionally been divided into 
several structural and functional domains (Fig. 1).2-4 The pyrimidine, ~­
aminoalanine, and ~-hydroxyhistidine moieties are necessary for iron binding 
and 02 activation.23-26 Although the carbamoyl disaccharide moiety 
increases the efficiency of DNA cleavage, deglycobleomycin cleaves DNA 
with similar sequence specificity to that of bleomycin and produces the same 
DNA degradation products.24,27-29 A polypeptide linker region separates the 
iron-binding domain from the bithiazole moiety and the positively charged 
tail, which are necessary for sequence-specific recognition of DNA.26,30-32 
That bleomycin models and analogs, some of which are deficient in sequence-
specific DNA-cleaving activity, are capable of oxygen activation25,33,34 
suggests the possibility of constructing novel hybrid sequence-specific DNA-
cleaving molecules in which the iron-binding domain of bleomycin is 
attached to a heterologous binding domain. 
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Bifunctional Design. 
In an effort to harness the DNA cleaving activity of bleomycin to DNA-
binding molecules with greater sequence selectivity, Zarytova and colleagues 
have devised a method to couple intact Bleomycin As to 
oligonucleotides.35,36 These oligonucleotide-BLM conjugates cleave 
complementary strands of DNA through a non-diffusible species with a 
specificity reflective of both the oligonucleotide and bleomycin moieties of 
the conjugate. In a complementary approach, Ohno and co-workers have 
synthesized a novel DNA-cleaving molecule in which a model bleomycin 
ligand, termed PYML-6, is attached through an appropriate linker to 
distamycin.37 The resulting ligand displays distamycin-like specificity, 
binding to and cleaving DNA at A,T-rich sites. However, instead of the 
single-nucleotide cleavage patterns seen with bleomycin, the cleavage 
patterns obtained are broad and reminiscent of the cleavage patterns produced 
by Fe• EDTA-distamycin, which cleaves DNA through a diffusible species, 
presumably hydroxyl radical.38-40 Although these studies constitute 
promising leads for the design of novel bifunctional molecules, it remains to 
be shown that the iron-binding domain is capable of mechanistically similar 
cleavage to that effected by bleomycin when it is attached to a heterologous 
DNA binding domain. 
DNA-Binding Domain of Hin Recombinase. 
Hin Recombinase is a 190 amino acid enzyme that inverts a segment of 
DNA that controls the expression of the flagellin genes in Salmonella 
typhimurium .41 Hin binds as a dimer to a number of similar DNA sites 
with the consensus half-site sequence 5'-TTNTCNNAAACCA-3'.41,42 On 
the basis of sequence similarity with repressor proteins, Hin is thought to 























































































































































































































































































































































acid peptide identical to the C02H-terminus of Hin (residues 139-190) and 
containing the putative helix-turn-helix region has been shown to constitute 
the sequence specific DNA-binding activity of Hin.44 Attachment of 
EDTA•Fe to the DNA-binding peptide Hin(139-190) affords a DNA-cleaving 
peptide that mediates oxidative degradation of the DNA at Hin binding sites 
via a diffusible oxidant.45-47 Affinity cleaving studies using Hin(139-190) 
equipped with the EDTA•Fe at the NH2 terminus have revealed that the 
NH2 terminus of Hin(139-190) lies proximal to the minor groove near the 
symmetry axis of Hin recombination sites.47 Affinity cleaving studies with 
Fe•EDTA attached near the C02H terminus of Hin(139-190) have 
demonstrated that the recognition helix of the helix-turn-helix element is 
oriented toward the symmetry axis of the DNA binding site.48 A binding 
model put forward for Hin(139-190) includes a helix-turn-helix-turn-helix 
structure binding in the major groove with residues at the NH2 terminus 
extending across the phosphodiester backbone making specific contacts in the 
minor groove (Fig. 5A).47-49 The importance of these additional NH2-
terminal minor groove contacts has been demonstrated through methylation 
interference assays,42 mutation of Hin recombination sites,SO and affinity 
cleaving studies with proteins truncated at the NH2-terminus.49 
Ni(II) • GGH-Hin(130-190). 
A second type of hybrid protein, consisting of all naturally-occurring a.-
amino acids has been synthesized. This protein, GGH-Hin(139-190), contains 
the tripeptide consensus sequence for the copper-binding domain of serum 
albumin, Gly-Gly-His, attached to the NH2 terminus of the DNA-binding 
domain of Hin recombinase.Sl GGH-Hin(139-190) cleaves DNA at Hin 
binding sites in the presence of Cu(II), hydrogen peroxide, and sodium 
122 
ascorbate51 or in the presence of Ni(II) and monoperoxyphthalic acid (Fig. 
SB).52 Cleavage by Ni•GGH-Hin(139-190) is rapid and efficient and occurs 
predominantly at a single deoxyribose position at each Hin binding site, 
indicating cleavage by a highly localized, nondiffusible oxidizing species.52,53 
A significant deuterium isotope effect at H4' has been measured for DNA 
cleavage by Ni•GGH-Hin(139-190)/monoperoxyphthalic acid, implying that 
oxidative DNA degradation by this protein results from hydrogen abstraction 
at the 4'-position of the deoxyribose backbone.54 Thus, the DNA-binding 
domain of Hin recombinase can support DNA cleavage in the adjacent minor 

















Fig. 6. (A) Synthetic protein PBA-~-OH-His-Hin(139-190). (B) Sequence of the 
C02H-terminal 52 amino acids(139-190) of Hin recombinase. Sequence is 
shown from the NH2 terminus of the peptide to its C02H terminus. 
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Strategy for the Synthesis of the Bleomyin-Hin Conjugate Protein. 
This chapter describes the synthesis and DNA-binding and -cleaving 
properties of a 54-residue protein hybrid protein, PBA-J3-0H-His-Hin(139-190) 
(Fig. 5C,6). This protein comprises the DNA-binding domain of Hin 
recombinase, residues 139-190, and the putative iron-binding and oxygen-
activating domain of bleomycin, pyrimidoblamic acid-erythro-J3-hydroxy-L-
histidine (PBA-J3-0H-His). The chemical synthesis of Hin(139-190) by solid 
phase methods is well known.44,47-49,55 Syntheses of pyrimidoblamic 
acid56-60 and erythro-J3-hydroxy-L-histidine61-64 have been reported by 
several groups. Because these synthetic efforts were part of a larger program 
toward the total synthesis of bleomycin65,66 or deglycobleomycin,58 PBA and 
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Figure 7. Retrosynthetic strategies for the synthesis of Boc-pyrimidoblamic 
acid. 
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Boc-pyrimidoblamic acid. Early chemical studies demonstrated that 
acylation of pyrimidoblamic acid occurs readily only at the primary amine of 
the P-aminoalanine moiety. Retrosynthetic analyses for two approaches to 
Boc-pyrimidoblamic acid are shown in Figure 7. In one approach (Fig. 7 A), 
developed by Ohno and co-workers,59 an imine was formed from a 
pyrimidine aldehyde and from a Boc-protected-amino-alanine-amide 
derivative. The acetamido side chain was then introduced via the addition of 
the dibutyl boronyl enolate derived from tert-butyl thioacetate, leading to a 1:1 
mixture of diastereomers. Hecht and co-workers, on the other hand, chose to 
construct a bromopyrimidine moiety with the acetamido side chain intact 
(Fig. 7B).56 The bromopyrimidine moiety was then treated with the Boc-
protected-amino-alanine-amide to provide the nucleus of Boc-
pryrimidoblamic acid as a 1:1 mixture of diasteromers. 
More recent work by Boger and co-workers58 has applied the general 
approach of the Ohno group with two major modifications : a 
diastereoselective introduction of the acetamido side chain was achieved 
using a stannous enolate of a chiral oxazolidinone species69 (Fig. 8A), and the 
pyrimidine moiety was generated from the inverse-electron demand Diets-
Alder reaction of 2,4,6-tris(ethoxycarbonyl)-1,3,5-triazine with propionami-
dine hydrochloride (Fig. BB)?O 
erythro-{3-Hydroxy-L-Histidine. A diastereoselective approach to the 
synthesis of P-OH-His has also been reported.63 In this synthesis, the key step 
is the addition of the dibutylboronyl enolate of a chiral oxazolidinone to a 
protected imidazole-4-carboxaldehyde derivative (Fig. 9). This strategy has 
been modified by Boger and co-workers64 to afford a P-OH-His suitable for 
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Figure 8. Key reactions in the synthesis of (A, B) Boc-pyrimidoblamic acid52 
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Figure 9. (A) Synthesis of the amine moiety 4. (B) Synthesis of the pyrimidine 
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Figure 10. Diastereoselective enolate addition and subsequent functional 
group manipulation to yield Boc-pyrirnidoblamic acid. 
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RESULTS 
Synthesis of the Protected Bleomycin Ligand. Boc-pyrimidoblamic acid 
(15) was synthesized following the procedures reported by Boger and co-
workers.58 The synthetic scheme and the yields obtained for each reaction are 
shown in Figures 9 and 10. The protected 13-0H-His derivative 16 was 
prepared, coupled to Boc-pyrimidoblamic acid, and deprotected by Dr. Ken 
Turnbull according to the procedure of Boger and co-workers58,64 to afford 
the PBA-13-0H-His derivative 18 (Fig. 11). 
~N~~Me O H,N~H H NHBoc 
H,N~O H \_.NHBoc HO \ \ N~ NH, 
N~N~ N 0 
"' 0 E:::l. H::: H,N~~~~Me LiOH 
H2N .& O Ct;, 0 HO N 
CH, 00 \ ., 
N 
15 17 O'h, 
Figure 11. Synthesis of a suitably protected PBA-13-0H-His 
peptide synthesis. 
derivative for 
Peptide Synthesis. 18 was coupled to the NH2-terminus of resin-bound 
and protected Hin(139-190)47-49,55 under standard coupling conditions to 
afford 19 in 88% yield (Fig. 12). The protein was deprotected with anhydrous 
HF and purified by preparative reverse-phase HPLC to afford PBA-13-0H-His-
Hin(139-190) (Fig. SC, 6). The synthesis of PBA-13-0H-His-Hin(139-190) was 
confirmed by laser desorption time-of-flight mass spectrometry. As a control 
to ensure that the PBA-13-0H-His dipeptide withstands HF treatment, 1758 
was subjected to anhydrous HF under the conditions used for peptide 
deprotection to afford 20 in quantitative yield (Fig. 13). 
DNA Binding and Cleaving. The DNA-binding and -cleaving properties 
of PBA-13-0H-His-Hin(139-190) were investigated by footprinting and affinity 




anhydrous HF ~ 
Hin(139-190) 
Figure 12. Synthetic scheme for the attachment of the protected PBA-13-0H-
His derivative 18 to the NH2 terminus of resin-bound Hin(139-190) by solid 
phase methods and deprotection of the resulting protein. 
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Figure 13. Scheme for the model HF deprotection of 17. 
bp binding sites for Hin recombinase: two full dimeric binding sites termed 
hixL and secondary, and a lower affinity site, tertiary (Fig. 14). The individual 
half sites are termed IRL and IRR, with the IRL sites on the left and IRR on 
the right side (Fig. 16; bottom and top, respectively, in Fig. 15) of the center of 
the full site. Deoxyribonuclease (DNase) I footprinting and affinity cleaving 
results are shown in Fig. 15, and histogram representations of the data are 
shown in Figure 16. 
A. major minor 

















Figure 14. A. Consensus Hin half-site showing positions contacted in the 
major and minor grooves.42,50 B. Sequences of the Hin half-sites assayed. 
Bases implicated in specific contacts are printed in bold type.SO 
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Figure 15. Autoradiogram of a high-resolution denaturing polyacrylamide 
gel showing DNase I footprinting reactions for Hin(139-190) and PBA-~-OH­
His-Hin(139-190) and affinity cleaving reactions for Fe•PBA-~-OH-His­
Hin(139-190), Fe• EDT A-Hin(139-190), Ni • GGH-Hin(139-190), and 
Fe• Bleomycin. Lanes 1, 3, 5-7, 11, 13, 15, and 17 contain 5'_32P-end-labeled 
DNA; lanes 2, 4, 8-10, 12, 14, 16, and 18 contain 3'_32P-end-labeled DNA. Lanes 
1 and 2, intact DNA; lanes 3 and 4, Maxam-Gilbert G-specific sequencing 
reactions; lanes 5 and 8, DNase control lanes; lanes 6 and 9, DNase I cleavage 
protection by Hin(139-190) (5~M); lanes 7 and 10, DNase I cleavage protection 
by PBA-~-OH-His-Hin(139-190) (5~M); lanes 11 and 12, Fe•PBA-~-OH-His­
Hin(139-190) at 10 ~M; lanes 13 and 14, Fe•EDTA-Hin(139-190) at 5~M; lanes 
15 and 16, Ni•GGH-Hin(139-190) at 5~M; lanes 17 and 18, Fe•Bleomycin at 2.5 
~M. 
1 32 
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Figure 16. The sequence from left to right represents the data from the 
bottom to the middle of the gel shown in Fig. 15. (A) Bars represent the extent 
of protection, derived from the ratio of cleavage at each band compared to the 
control lane, from DNase I cleavage in the presence of 5 J..l.M Hin(139-190) 
(Fig. 6, lanes 6 and 9). (B) Bars represent the extent of protection from DNase I 
cleavage in the presence of 5 J..l.M PBA-~-OH-His-Hin(139-190) (Fig. 6, lanes 7 
and 10). (C) Arrows represent the extent of cleavage by 10 J..l.M Fe•PBA-~-OH­
His-Hin(139-190) (Fig. 6, lanes 11 and 12). (D) Arrows represent the extent of 
cleavage by 5 J..l.M Fe•EDTA-Hin(139-190) (Fig. 6, lanes 13 and 14). (E) Arrows 
represent the extent of cleavage by 5 J..l.M Ni•GGH-Hin(139-190) (Fig. 6, lanes 
15 and 16). (F) Arrows represent the extent of cleavage by 2.5 J..l.M 
Fe•Bleomycin (Fig. 6, lanes 17 and 18). 
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In the presence of the reductant DTI, Fe•PBA-13-0H-His-Hin(139-190) at 
10 ~M cleaves the restriction fragment at every site cleaved by Fe•EDTA-
Hin(139-190) at 5 ~M, although with lower intensity (Fig. 15, lanes 11-14; Fig. 
16C,D). Additional cleavage is not observed at Fe• Bleomycin sites, indicating 
that the DNA-binding and -cleaving specificity of Fe•PBA-13-0H-His-Hin(139-
190) is largely determined by the Hin DNA-binding domain (Fig. 15, lanes 17, 
18; Fig. 16F). Only one new set of cleavage bands is observed for Fe•PBA-13-
0H-His-Hin(139-190), adjacent to the tertiary site. As is the case with 
Fe•EDTA-Hin(139-190), Fe•PBA-13-0H-His-Hin(139-190) cleavage occurs over 
several bases on each strand of DNA at each site. Densitometry traces 
comparing the cleavage patterns generated by Fe•EDTA-Hin(139-190) and 
Fe•PBA-13-0H-His-Hin(139-190) at hixL are shown in Fig. 17. Although 
cleavage by Fe•PBA-13-0H-His-Hin(139-190) is less efficient than that by 
Fe•EDTA-Hin(139-190), the shapes of the patterns are almost identical. This 
broad cleavage is in contrast to the cleavage observed with NiGGH-Hin(139-
190), which cleaves each half site of hixL predominantly at one nucleotide on 
one strand (though cleavage at two nucleotide positions on each strand is 
seen at secondary, which is cleaved much less efficiently than hixL) (Fig. 15, 
lanes 15, 16; Fig. 16E). Cleavage by Fe•PBA-13-0H-His-Hin(139-190) is also 
much more diffuse than that by Fe•Bleomycin (2.5 ~M), which occurs only at 
a single base on one strand of each site. 
Qualitative DNase I footprinting reactions demonstrate that the reduced 
intensity of cleavage by Fe•PBA-13-0H-His-Hin(139-190) is not due to reduced 
binding affinity (Fig. 15, lanes 5-10). PBA-13-0H-His-Hin(139-190) protects both 
half sites of the hixL from cleavage by DNase I at approximately the same 
positions as Hin (139-190) and with roughly equal affinity at a concentration 
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3'-labeled DNA 5'-labeled DNA 
Figure 17. Densitometry traces of the cleavage by Fe•EDTA-Hin(139-190) 
(upper traces) and Fe•PBA-f3-0H-His-Hin(139-190) (lower traces, expanded by 
a factor of 7) at the binding site hixL. 
of 5 ~M (Fig. 15, lanes 5-10; Fig. 16A,B). Protection at the secondary half sites 
appears to be reduced slightly relative to Hin(139-190); however, this 
reduction is insufficient to account for the greatly diminished cleavage 
intensity. 
Time Course for the Reaction . The time course for the affinity cleaving 
reaction of Fe•PBA-f3-0H-His-Hin(139-190) at 5 ~Min the presence of DTT is 
shown in Figure 18. Cleavage intensity increased for several hours before 
leveling off after about six hours, in direct contrast to cleavage by bleomycin, 
which is complete within 30 minutes, the first time at which a measurement 
was taken. The Fe•PBA-f3-0H-His-Hin(139-190) cleavage reaction is also 
much slower than that by Fe•EDTA-Hin(139-190), which has a half life of 
about ten minutes and levels off after an hour?1 
Quantitative DNase I Footprint Titrations . To examine more fully the 
affinity of PBA-f3-0H-His-Hin(139-190) for the various Hin binding sites and 
to determine whether metal complexation affects its binding to DNA, relative 
association constants for Fe•PBA-f3-0H-His-Hin(139-190), PBA-P-OH-His-
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Figure 18. Time course for the Fe• PBA-!3-0H-His-Hin(139-190) and 
Fe • Bleomycin cleavage reactions. Open circles represent background 
cleavage; filled circles represent specific cleavage. 
Hin(139-190), and Hin(139-190) were determined through quantitative DNase 
I footprint titration analyses (see experimental section)?2 A typical gel is 
shown in Figure 19. The relative association constants for each of the three 
proteins at four different Hin binding sites are shown in Table I; the corre-
sponding binding isotherms for the hixL IRL site are shown in Figure 20. The 
Table I. Binding constants for Fe•PBA-(3-0H-His-Hin(139-190), PBA-(3-0H-His-Hin(139-
190), and Hin(139-190) at four DNA binding sites measured by quantitative DNase I 
f ootpnnt htrattons. 
Site Protein Relative Kaapp a,b 
hixL IRL Hin(139-190) 1.0 (0.3) 
PBA-(3-0H-His-Hin(139-190) 1.1 (0.2) 
Fe• PBA-(3-0H-His-Hin(139-190) 1.3 (0.4) 
hixLIRR Hin(139-190) 1.6 (0.5) 
PBA-(3-0H-His-Hin(139-190) 1.9 (0.4) 
Fe• PBA-[3-0H-His-Hin(139-190) 1.8 (0.4) 
secondary IRL Hin(139-190) 0.26 (0.04) 
PBA-(3-0H-His-Hin(139-190) 0.11 (0.03) 
Fe• PBA-~-OH-His-Hin(139-190) 0.13 (0.03) 
tertiary Hin(139-190) < 0.07 
PBA-[3-0H-His-Hin(139-190) <0.07 
Fe• PBA-(3-0H-His-Hin(139-190) <0.07 
a Values reported are calculated from the average data from three or four footprint titration 
experiments. Relative values are based on the Kaapp for Hin(139-190) at the hixL IRL site. 
Numbers in parentheses indicate the standard deviation for the data set. b The assays were 
performed at room temperature, pH 7.6, in the presence of 20 mM bis-Tris-HCl, 20 mM sodium 
chloride, 10 mM magnesium chloride, and lOOJ..LM calf thymus DNA. 
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Figure 19. Autoradiogram of a high-resolution denaturing 6% polyacrylamide 
gel showing quantitative DNase I footprinting titration reactions for PBA-J3-
0H-His-Hin(139-190). All lanes contain s •_32P-end-labeled DNA. Lane 1, 
DNA; lane 2, A-specific sequencing reaction; lane 18, DNase control lane; 
lanes 3-17 show DNase I cleavage protection by PBA-J3-0H-His-Hin(139-190) at 
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Figure 20. Langmuir binding isotherms derived from quantitative DNase I 
footprint titration experiments for Hin(139-190), PBA-P-OH-His-Hin(139-190), 
and Fe•PBA-P-OH-His-Hin(139-190) at hixL IRL. The 8norm values were 
obtained using photostimulable storage phosphor autoradiography as 
described in the Experimental Section. 
binding constants for all three proteins are within experimental error of one 
another in all cases except for secondary IRL, at which Hin(139-190) appears to 
display slightly stronger affinity than the other two proteins. 
Cleavage of DNA by Fe•20 A time course and concentration profile for 
the cleavage of DNA by Fe•20 is shown in Figure 21 (lanes 7-13). Clearly, this 
complex cleaves non-specifically and only at high concentrations (> 100 ~M). 
In fact, Fe•20 cleaves no better than Fe(II) at the same concentrations (lanes 
21-24) and slightly less efficiently than Fe•EDTA (lanes 14-20). As is the case 
with Fe•PBA-P-OH-His-Hin(139-190), Fe•20 cleaves more slowly than its 
EDTA counterpart. Cleavage by the free acid counterpart of Fe•20 (prepared 
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Figure 21. Gray-scale representation of a storage phosphor autoradiogram of a 
high-resolution denaturing polyacrylamide gel showing DNA cleaving 
reactions for Fe•20 (Fe•PBA-~-OH-His-OMe), its corresponding acid complex 
(Fe•PBA-~-OH-His-OH), Fe•EDTA and Fe. Unless otherwise noted, reactions 
were allowed to proceed for 6 h . All lanes contain 5'-32P-end-labeled DNA. 
Lane 1, intact DNA; lane 2, Maxarn-Gilbert G-specific sequencing reaction. 
Lanes 3-6, Fe•PBA-~-OH-His-OH at concentrations of 180, 90, 18, and 9 IJ.M, 
respectively. Lanes 7-13, Fe•20; lanes 7-10 contain 180 IJ.M complex reacting 
for 0.5, 1, 2, and 6 h, respectively; lanes 11-13 contain 90, 18, and 9 IJ.M complex, 
respectively. Lanes 14-20, Fe • EDT A; lanes 14-17 contain 180 IJ.M corn plex 
reacting for 0.5, 1, 2, and 6 h, respectively; lanes 18-20 contain 90, 18, and 9 IJ.M 
complex, respectively. Lanes 21-24, Fe(II) alone at concentrations of 180, 90, 
18, and 9 IJ.M, respectively. 
142 
143 
by Dr. Ken Turnbull) is also shown (lanes 1-4); it is indistinguishable from 
that by Fe•20. 
End Product Analysis by Gel Electrophoresis. The identity of the DNA 
end products of cleavage by Fe•PBA-13-0H-His-Hin(139-190) and Fe•20 was 
investigated by 20% polyacrylamide gel electrophoresis on a restriction 
fragment containing the Hin binding site secondary.54 The 5'-end products 
generated by Fe•Bleomycin, MPE•Fe, Fe•PBA-13-0H-His-Hin(139-190) and 
Fe•20 are shown in Figure 22. In each case, the 5'-end products, known in the 
case of MPE and bleomycin to be phosphate,46 have the same electrophoretic 
mobility. Treatment of the end products with alkaline phosphatase results in 
a slowing of the electrophoretic mobility as would be expected from the 
formation of hydroxyl ends. Although the Fe•PBA-13-0H-His-Hin(139-190) 
reaction has not proceeded to completion, other gels have shown complete 
reaction, indicating that the major 5'-end product is phosphate. The 3'-end 
products generated by the same affinity cleaving agents are shown in Figure 
23. MPE•Fe is known to produce a roughly equal mixture of 3'-phosphate and 
-phosphoglycolate.46 The two products are not clearly resolved in this gel. 
However, treatment of the end products with polynucleotide kinase to 
remove the 3'-phosphate groups (but leaving 3'phosphoglycolate intact)73 
results in an upward electrophoretic shift of approximately half the material, 
consistent with an initial equal mixture of phosphate and phosphoglycolate 
end products. In contrast, no electrophoretic shift is seen when the 
bleomycin-derived end products are treated with kinase in the absence of base 
treatment, consistent with the exclusive production of 3'-phosphoglycolate 
ends (Figs. 3, 4). Treatment with butylamine followed by kinase leads to an 
electrophoretic shift, indicating that phosphate is produced by the base 
treatment, as expected (Fig. 4). For both Fe•PBA-13-0H-His-Hin(139-190) and 
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Figure 22. Gray-scale representation of a storage phosphor autoradiogram of a 
denaturing 20% polyacrylamide gel showing the 5'-end products of DNA 
cleavage by Fe(II)•PBA-~-OH-His-Hin(139-190) and Fe(II)•20. Even numbered 
lanes 4-10 show reactions treated with calf alkaline phosphatase to remove 3'-
phosphate groups. Lane 1, DNA standard lane. Lane 2, A- specific reaction. 
Lanes 3 and 4, MPE•Fe reactions, -13, 000 cpm DNA. Lanes 5 and 6, 
Fe•Bleomycin reactions, -10,000 cpm DNA. Lanes 7 and 8, Fe(II)•PBA-~-OH­
His-Hin(139-190) reactions, -17,000 cpm DNA. Lanes 9 and 10, Fe(II)•20 
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Figure 23. Gray-scale representation of a storage phosphor autoradiogram of a 
denaturing 20% polyacrylamide gel showing the 3'-end products of DNA 
cleavage by Fe(II)•PBA-J3-0H-His-Hin(139-190) and Fe(II)•20. Even numbered 
lanes 4-16 show reactions treated with T4 polynucleotide kinase to remove 3' 
phosphate groups. Lane 1, DNA standard lane. Lane 2, Maxam-Gilbert G-
reaction. Lanes 3 and 4, MPE • Fe reactions, -9000 cpm DNA. Lanes S-8, 
Fe•Bleomycin reactions, -9000 cpm DNA. Lanes 7 and 8 are with base 
workup. Lanes 9-12, Fe(II)•PBA-J3-0H-His-Hin(139-190) reactions, -9000 cpm 
DNA. Lanes 11 and 12 are with base workup. Lanes 13-16, Fe(II)•20 reactions, 
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Fe•20, phosphate ends are the major product both in the presence and in the 
absence of base treatment. 
DISCUSSION 
The hybrid protein Fe•PBA-P-OH-His-Hin(139-190) containing the 
DNA-binding domain of Hin recombinase and the metal-binding and 
oxygen-activating domain of bleomycin binds to and cleaves DNA with the 
desired specificity. However, the cleavage pattern is much broader than that 
expected for cleavage by a nondiffusible oxidant such as that found in 
bleomycin. Formally, this data can be interpreted in two ways: cleavage could 
occur through a diffusible oxidizing species, such as hydroxyl radical, or a 
number of nucleotide positions could be accessible to a highly localized 
oxidant. The second explanation would require significant mobility of the 
NH2-terminal segment of Fe•PBA-P-OH-His-Hin(139-190). However, the 
available evidence indicates that this segment is firmly anchored in the 
minor groove. The Ni•GGH-Hin(139-190) cleavage pattern, the result of 
cleavage by a localized oxidant, suggests that the NH2-terminal segment is 
held in place in the minor groove.52,53 Affinity cleaving studies have shown 
the NH2-terminal Gly-Arg-Pro-Arg sequence to be necessary for DNA 
binding?4,75 For example, deletion of the two NH2-terminal residues, Gly-
139 and Arg-140, leads to a dramatic reduction in DNA affinity and alteration 
of DNA-binding specificity.49 No such change in binding is observed with 
Fe•PBA-P-OH-His-Hin(139-190), suggesting that the best explanation for the 
observed cleavage pattern is that the DNA is cleaved by a diffusible oxidant. 
The DNA end products generated by Fe•PBA-P-OH-His-Hin(139-190) 
have been analyzed by gel electrophoresis. The major products are 5'- and 3'-
phosphate, consistent with oxidative degradation of the deoxyribose 
149 
backbone. However, the appearance of 3'- phosphate termini in the absence 
of base treatment clearly demonstrates that DNA degradation by Fe•PBA-~­
OH-His-Hin(139-190) does not proceed through the same pathway as 
bleomycin-induced degradation, for which no 3'-phosphate is observed in the 
absence of base treatment. It is well established that degradation of DNA by 
bleomycin leads to two sets of products: base propenals are released along 
with 5' phosphate and 3' phosphoglycolate termini; and free base release is 
accompanied by formation of an alkali-labile lesion2-4,16,76,77. Only upon 
treatment with n-butylamine does this lesion produce 3'- and 5'- phosphate 
termini.22 
There are at least two possible explanations for cleavage by Fe•PBA-~­
OH-His-Hin(139-190) through a diffusible oxidant rather than through the 
localized oxidant found in bleomycin. First, the PBA-~-OH-His ligand might 
be insufficient to form the iron-oxo complex found in "activated bleomycin." 
Although we cannot rule out this explanation, the data suggests that 
complexes even simpler than PBA-~-OH-His can activate oxygen. The 
spectral properties of such bleomycin analogs bound to Fe and oxygen 
analogs are very similar to those of bleomycin, suggesting a similar ternary 
complex is formed .24 The activity of these analogs has also been confirmed 
by a spin trapping assay for the presence hydroxyl and superoxide radicals.24 
More compelling evidence for bleomycin-like oxygen activation is the 
demonstration that analogs of bleomycin can transfer oxygen to small organic 
substrates. For example, an iron complex consisting of the pyrimidoblamic 
acid, hydroxy-histidine and methylvalerate moieties has been shown to 
transfer oxygen to stilbene in the presence of iodosobenzene or oxygen and 
ascorbate. 25 Similarly, Hecht and co-workers have demonstrated that 
deglycobleomycin analogs in which one of the two thiaziole units has been 
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replaced with cysteine also give non-specific cleavage and produce 3'-
phosphate termini in the absence of a base workup. 78 As the thiazole units 
are not likely to participate in iron binding and oxygen activation, this study 
demonstrates that bleomycin analogs with intact oxygen activation domains 
can display behavior similar to that seen for Fe•PBA-J3-0H-His-Hin(139-190). 
An alternative explanation for diffusible cleavage is that the appropriate 
activated iron-oxygen complex is formed but is not held in the appropriate 
position to permit reaction of the non-diffusible oxidant with the deoxyribose 
backbone. Breakdown of the complex could then produce a diffusible oxidant 
that could cleave DNA proximal to the position of the metal complex. In 
support of this, Fe•Bleomycin has been shown by spin-trapping experiments 
to generate hydroxyl radicals in the presence of oxygen?9 Previous studies 
with nickel and copper complexes of GGH-Hin(139-190) illustrate the 
sensitivity of the cleavage reaction to small changes in the metal-ligand 
complex and the DNA structure. For example, although GGH-Hin(139-190) 
binds efficiently to both the hixL and secondary full sites, Cu •GGH-Hin(139-
190) cleaves primarily at the secondary IRR site while Ni•GGH-Hin(139-190) 
cleaves much more efficiently at the hixL site.51,52,79 
Because of the precise spatial requirements for DNA degradation by a 
nondiffusible oxidant, we chose a DNA-binding protein that has been shown 
to support oxidative DNA cleavage by a reactive metal complex through 4'-H 
abstraction. A comparison of the proposed structures of the metal complexes 
for bleomycin2 and GGH80-83 (Fig. SB and 2C, respectively) shows that the 
putative bleomycin equatorial ligands occupy very similar positions in the 
primary amino acid sequence of Fe•PBA-J3-0H-His-Hin(139-190) to those of 
the nickel ligands in Ni-GGH-Hin(139-190). However, the iron complex of 
the bleomycin ligand is considerably bulkier than the nickel complex of GGH, 
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perhaps resulting in its exclusion from the minor groove. Interestingly, the 
only Hin site at which cleavage by Fe•PBA-l3-0H-His-Hin(139-190) is 
comparable to that of Fe•EDTA-Hin(139-190) is the tertiary site. At this site 
the typical A,T rich minor groove Hin-binding sequences are replaced with 
G,C base pairs,84 leading to a wider minor groove and perhaps allowing the 
metal complex to position itself closer to the DNA backbone (Fig. 14).42,50 
This would explain the relatively efficient cleavage by Fe•PBA-l3-0H-His-
Hin(139-190) at this low affinity site. For Fe•EDTA-Hin(139-190), the smaller 
Fe•EDTA complex would allow the cleavage intensity to reflect its binding 
affinity more accurately. 
Another possibility is that the metal binding ligand of bleomycin has 
sequence-specific requirments for DNA binding or cleaving that are not met 
by the five Hin binding sites assayed in this study. Several lines of evidence 
support the view that the iron-binding domain is a determinant of bleomycin 
sequence selectivity. A number of bleomycin analogs having identical C02H-
terrnini but differing in the metal-binding domain exhibit modified sequence 
and strand selectivity.l2,29 Similarly, DNA unwinding by bleomycin is 
markedly reduced in the absence of a metal ion.85 In addition, bleomycin 
analogs containing linkers of variable lengths (0 to 4 glycine residues) 
between the metal-binding ligand and the bithiazole moiety cleave DNA at 
the same nucleotides.86 Finally, a recent report demonstrates that Fe(II) and 
Fe(II) complexes of a bleomycin model ligand cleave DNA with reasonable 
efficiency and with a cleavage specificity remarkably similar to that of 
bleomycin. 34 
There are very few good bleomycin cleaving sites in proximity to the 
Hin binding sites assayed in this work (Fig. 15, lanes 17-18; Fig 16A). The only 
exception occurs at secondary, where very efficient cleavage by Fe•bleomycin 
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is seen at a 5'-GT-3' sequence. However, cleavage by Fe•PBA-f3-0H-His-
Hin(139-190) is no more efficient at this site than at any of the others. This 
raises the possiblity that the NH2-terminal segment of the protein is 
insufficiently flexible to allow the complex to position itself appropriately to 
react with the deoxyribose backbone at this site. 
In light of these considerations, we suggest that future experiments on 
hybrid DNA-cleaving molecules containing the iron-binding domain of 
bleomycin might include a DNA binding site with bleomycin recognition 
sites proximal to the recognition sequence of the DNA-binding molecule. In 
addition, in the absence of detailed structural information about the 
bleomycin-DNA complex, it may be necessary to optimize a linker moiety by 
trial and error for a suitable orientation of the bleomycin-derived DNA-
cleaving domain in the hybrid molecule. 
EXPERIMENTAL SECfiON 
Materials. 
Preparation of Boc-pyrimidoblamic acid. 1H and 13C NMR spectra were 
recorded on a General Electric QE-300 NMR. High resolution mass spectra for 
organic compounds were recorded using fast atom bombardment techniques 
at the Mass Spectrometry Facility of the University of California, Riverside. 
Infrared spectra were recorded on a Perkin-Elmer FTIR. Optical rotations 
were measured on a Jasco DIP-180 digital polarimeter. Flame- or oven-dried 
glassware was used for all reactions run under an argon atmosphere. Reagent 
grade chemicals were obtained from Aldrich and used as received unless 
otherwise noted. Tetrahydrofuran (THF) and diethyl ether (Et20) were 
distilled under nitrogen from sodium/benzophenone ketyl. Dichloro-
methane, diisopropylethyl amine, acetonitrile (ACN) and benzene were 
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distilled under nitrogen or argon from powdered calcium hydride. 
Dimethylformamide (DMF) was obtained as an anhydrous solvent from 
Aldrich. Tin(II) triflate was a generous gift from Rob Singer and Prof. Erick 
Carreria. Flash column chromatography was carried out using EM Science 
Kieselgel 60 (230-400 mesh) unless otherwise stated. Thin layer 
chromatography was performed on EM Reagents silica gel plates (0.5 mm 
thickness) . Compounds were visualized with shortwave ultraviolet light or 
iodine. Preparative TLC was performed on E. Merck reverse-phase 18 plates 
(0.25 mm thick) with a 254 nm fluorescent indicator. 
Protein Synthesis. Asn-(Phenylacetamido)methyl (PAM) resin, DMF, 
diisopropylethylamine (DIEA), dicyclohexylcarbodiimide (DCC) in 
dichloromethane, N-hydroxybenzotriazole (HOBt) in DMF, trifluoroacetic 
acid (TFA), and protected amino-acid derivatives were purchased from 
Applied Biosystems. Boc-L-His(DNP) was obtained from Fluka. 
Dichloromethane and methanol (HPLC grade) were obtained from 
Mallinckrodt; HOBt, p -cresol and p -thiocresol from Aldrich, and diethyl 
ether (low peroxide content) from Baker. Automated peptide synthesis was 
performed on an ABI 430A peptide synthesizer. Protein mass spectra were 
recorded at the Biotechnology Instrumentation Facility of the University of 
California, Riverside, on a laser desorption time-of-flight mass spectrometer. 
UV-vis spectra were recorded on a Hewlett-Packard Diode Array 
spectrophotometer. GGH-Hin(139-190) was prepared by David Mack. 
DNA Reactions. Doubly distilled water was further purified through the 
Milli Q filtration system from Millipore. Sonicated, deproteinized calf 
thymus DNA was purchased from Pharmacia and dissolved in H20 to a 
concentration of 2 mM in base pairs. Enzymes were obtained from 
Boehringer-Mannheim or New England Biolabs and used with the buffers 
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supplied unless otherwise noted. Glycogen was obtained from Boehringer-
Mannheim. Deoxyadenosine- 5'- [a- 32P]-triphosphate and adenosine- 5'-[y 
_32p]-triphosphate were obtained from Amersham. Bleomycin sulfate was 
purchased from Sigma and solutions were prepared based on an extinction 
coefficient derived from an E1% of 105 at 292 nm and the molecular weight of 
Bleomycin A2 sulfate. Monoperoxyphthalic acid (magnesium salt 
hexahydrate) was obtained from Aldrich. The plasmid pMFB36 was a gift of 
Dr. M. F. Bruist and Prof. M. I. Simon. The plasmid pDPM34 was prepared by 
David Mack. Cerenkov radioactivity was measured with a Beckman LS 3801 
Scintillation Counter. Storage phosphor technology autoradiography was 
accomplished using a Molecular Dynamics 400S Phosphorimager and 
ImageQuant software. Storage phosphor screens (Kodak #S0230) were 
purchased from Molecular Dynamics. 
Methods. 
0-Benzyl-a-N-(tert-butoxycarbonyl)-L-serinehydroxamic Acid (1).87 N-
Boc-L-serine (6 .4 g, 31 mmol, US Biochemical Corporation) was dissolved in 
THF (-65 mL). A solution of 0-benzylhydroxylamine (10 g, 63 mmol) in H20 
(-250 mL, pH 4.5) was added, and the apparent pH was readjusted to 4.5 by 
addition of 50% NaOH. A solution of DCC (12.8 g, 62 mmol) in THF (-200 
mL) was added dropwise over 30-40 min while the apparent pH was 
maintained by the dropwise addition of 1.0 M HCl. A white precipitate began 
to form almost immediately. The reaction mixture was stirred until the pH 
stopped rising (-2.5 h). THF was removed under reduced pressure and the 
slurry was filtered to afford a white solid residue consisting of the desired 
product and dicyclohexyl urea (DCU). This residue was suspended in hot 
ethyl acetate (- 200 mL) and filtered to remove the DCU. The filtrate was 
concentrated under reduced pressure and purified by flash column 
155 
chromatography (1 :1 ethyl acetate-hexanes, followed by 2:1 ethyl acetate-
hexanes) to afford 1 (7.4 g, 77%). The lH NMR data were in accord with those 
previously reported.87 MGO VII-61. 
3-[ (tert-Butoxycarbon yl)amino]-1-(benzyloxy)-2-azetidinone (2). 87 A 
flame-dried flask was charged with argon, 1 (3.5 g, 11 mmol), Ph3P (3 g, 11 
mmol) and THF (60 mL). To this solution was added dropwise (under argon 
and with stirring) a solution of diethylazadicarboxylate (DEAD) (1.8 mL, 11 
mmol) in THF (50 mL). After the addition was complete, the reaction mixture 
was heated to 60 °C for 4.5 h . THF was removed under reduced pressure and 
the residue was purified by flash column chromatography (2:1 hexanes-ethyl 
acetate) to afford 2 (2.6 g, 78%) as a white solid. The 1H NMR data were in 
accord with those previously reported .87 MGO VI-55. 
(25 )-3-[ (B enzy loxy) amino]-2-[ ( tert-butoxycarbon yl)-amino ]proprionamide 
(3).56 2 (12.2 g, 41.8 mmol) was dissolved in methanol (-70 mL), and the 
solution was cooled to 0 °C and saturated with NH3 for 10 min. The reaction 
mixture was stirred at 0 °C for 3.5 h and the solvent was removed under 
reduced pressure. The residue was recrystallized from ether-hexanes to afford 
3 (9.83 g, 76%) as a white solid. The 1H NMR data were in accord with those 
previously reported.56 MGO IV-28. 
(25)-3-amino-2-[(tert-butoxycarbonyl)-amino]proprionamide (4).56 A 
solution of 3 (1.1g, 3.7 mmol) in methanol (12 mL) was treated with 10% 
palladium-on-charcoal (218 mg) and maintained under a hydrogen 
atmosphere at room temperature for 4 h. The reaction mixture was filtered 
through Celite and the filtrate was concentrated under reduced pressure. The 
residue was purified by flash column chromatography (10%-MeOH- 2% Et3N-
MeCl2) to afford 4 (730 mg, 97%) as a white foam. The 1H NMR data were in 
accord with those previously reported.56 MGO VII-121. 
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Propionamidine Hydrochloride (5).70 A mixture of propionitrile (13 g, 
0.24 mol) and methanol (9.6 mL, 0.24 mol) was cooled to -20 oc and HCl (10.7 
g, 0.30 mol) was bubbled in while maintaining the temperature between -5 °C 
and -20 °C. The mixture was stirred at 0 °C for 45 min, during which time a 
white precipitate formed. Anhydrous Et20 (30 mL) was added and the 
solution was left unstirred for 3 h . The solution was filtered to afford crude 
methyl propionimidate (22 g) as a pale yellow solid. The crude methyl 
propionimidate was suspended in absolute ethanol (100 mL), and a solution 
of NH3 (3 g, 0.2 mol) in absolute ethanol (60 g) was added; the resulting 
suspension was stirred at room temperature for 12 h. Solvent was removed 
under reduced pressure to afford 5 as a white solid (18 g, 70%). 1H NMR 
(DMSO-d6) revealed an unidentified contaminant. The partially purified 
material (13.6 g) was dissolved in hot methanol and the contaminating 
material was allowed to recrystallize. The solution was filtered and the 
filtrate was concentrated under reduced pressure to afford 5 (10.1 g, 71 %) 
with only trace contaminant. This removal of the contaminating material 
was not found to affect the yield of the subsequent reaction. 1H NMR (DMSO-
d6) was consistent with the structure of the desired compound. MGO VII-46. 
2,4,6-tris(Ethoxycarbonyl)-1,3,5-triazine (6).70 Into a flask containing neat 
ethyl cyanoformate (16.4 g, 166 mmol) was bubbled HCl (0.71 g, 20 mmol). 
The flask was tightly stoppered and allowed to react for 36 h, forming a pale 
yellow solid. The crude solid was recrystallized from absolute ethanol to 
afford pure 6 (11 .1 g, 67%) as a white solid. Analysis of the mother liquor 
revealed a substantial quantity of unreacted starting material, suggesting that 
the reaction had not gone to completion. 1 H NMR data were in accord with 
those previously reported. 70 MGO VII-117. 
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6-Amino-2,4-bis(ethoxycarbonyl)-5-methylpyrimidine (7).58 To a 
solution of 6 ( 2.7 g, 9.1 mmol) in DMF (45 mL) under an Ar atmosphere was 
added 5 (2.0 g, 19 mmol). The resulting reaction mixture was warmed at 100 
oc for 66 h. The solution was filtered, the solid residue was washed with 
methylene chloride and the filtrate was concentrated in vacuo to afford a dark 
brown solid. The crude residue was purified by flash column 
chromatography (2:1 EtOAc-hexanes) to afford 7 (1.5 g, 65%) as an off-white 
solid. 1H NMR data were in accord with those previously reported.S8 MGO 
VII-85. 
6-Amino-4-ethoxycarbonyl-2-hydroxymethyl-5-methylpyrimidine (8).58 
A solution of 7 (1.0 g, 4.0 mmol) in anhydrous ethanol was cooled to -5 °C 
and treated with sodium borohydride (159 mg, 4.0 mmol) under an Ar 
atmosphere. After stirring for 5 days at 0 °C, the reaction mixture was 
quenched by the addition of saturated NaHC03 (20 mL) and aqueous H202 
(5%, 20 mL) at 0 °C. The mixture was stirred 5 h and extracted with 20% 
isopropanol-CHCl3 (5 x 40 mL). The combined organic extracts were dried 
(MgS04) and concentrated in vacuo to afford a white solid. The crude residue 
was purified by flash column chromatography (1 :1 EtOAc-hexanes until the 
desired product began to elute, then 2:1 EtOAc-hexanes) to afford 8 (340 mg, 
41%) as a white solid. 1H NMR data were in accord with those previously 
reported. 58 MGO VTI-148. 
6-Amino-4-ethoxycarbonyl-5-methylpyrimidine-2-carboxaldehyde (9).58 
A solution of 8 (SO mg, 0.24 mmol) in acetonitrile was treated under an Ar 
atmosphere at room temperature with activated Mn02 and the resulting 
reaction mixture was warmed at 82 °C for 3 h. The mixture was allowed to 
cool to room temperature and filtered through a Celite pad (5 x 10 mL 
acetonitrile). The solvent was removed in vacuo and the residue was purified 
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by flash column chromatography (EtOAc) to afford 8 (33 mg, 66%) as a white 
foam. lH NMR data were in accord with those previously reported.58 MGO 
Vll-153. 
No.._(tert-Butoxycarbonyl)-Nf>-[(6-ethoxycarbonyl-4-amino--5-methylpyr-
imidin-2-yl) methyl]-(S)-~-aminoalanine amide (10) .58 To a flame-dried flask 
charged with Ar and crushed activated 3 A molecular sieves (520 mg) were 
added solution of 9 (30.0 mg, 0.144 mmol) in acetonitrile (2 mL) and a 
solution of 4 (37.9 mg, 0.188 mmol) in acetonitrile (3 mL). The resulting 
mixture was stirred at room temperature for 19.5 h, then filtered through a 
Celite pad . After washing with methylene chloride, the fitrate was 
concentrated in vacuo to afford 10 (54.3 mg, 96%) as a white foam. 1H NMR 
data were in accord with those previously reported.58 MGO VII-154. 
(4S, SR)-3-(Methylthioacetyl)- 4-methyl- 5- phenyl -2- oxazolidinone 
(11).88,89 To a cooled solution (-78 °C) of (45, 5R)-4-methyl-5-phenyl-2-
oxazolidinone (LOg, 5.6 mmol) in THF (12 mL) under an Ar atmosphere was 
added dropwise n-butyl lithium (1.6 M in hexanes, 3.5 mL, 5.6 mmol). The 
resulting solution was stirred at -78 °C for 2 h. 2-Thiomethyl acetyl chloride90 
(550 J.!.L, 5.6 mmol) was added to the solution, followed by stirring for an 
additional 90 minutes and allowed to warm to room temperature. The 
solution was treated with saturated aqueous ammonium chloride (6 mL), and 
the THF was removed under reduced pressure and the water layer was 
extracted with ether (3 x 10 mL). The combined organic extract was washed 
successively with saturated aqueous sodium bicarbonate (10 mL), brine (10 
mL), and water (10 mL) and dried (MgS04). Removal of the solvent under 
reduced pressure followed by purification of the residue by flash column 
chromatography (4:1 hexanes-ethyl acetate) yielded 11 (850 mg, 57%) as a 
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crystalline product. 1 H NMR data were consistent with those previously 
reported.88-90 MGO Vl-146. 
Ethyl (S)-2-[1-[[(S)-2- tert-Butyloxycarbonyl)amino]- 2-carbamoylethyl]-
amino]-2-[((4S, SR)-4-methyl- 5- phenyl- 2- oxazolidinyl) carbonyl]- 3-((S)-2-
methylthio-1-ethyl]-6-amino-5-methylpyrimidine-4-carboxylate (12).58 Tin(II) 
trifluoromethanesulfonate (500 mg, 1.2 mmol) was dissolved in THF (2 mL) 
under an Ar atmosphere and cooled to -78 °C. The cooled solution was 
treated sequentially with 11 (210 mg, 0.80 mmol) in THF (2 mL) and freshly 
distilled iPr2NEt (236 ~L, 1.35 mmol). The mixture was stirred 1 h at -20 °C 
then recooled to -78 °C. A solution of 10 (95 mg, 0.24 mmol) in THF (2 mL) 
was added and the resulting mixture was allowed to warm to 0 °C where it 
was allowed to stir for 12 h under an Ar atmosphere. The reaction mixture 
was poured into a two-layer solution of CH2Cl2 (30 mL) and saturated 
aqueous sodium bicarbonate (15 mL) with vigorous shaking. The organic 
layer was washed with brine (2 x 10 mL), dried (MgS04), and concentrated 
under reduced pressure. Flash column chromatography (2% MeOH-CH2Cl2) 
of the resulting residue afforded partially purified 12 (250 mg, theoretical yield 
160 mg). This residue was dissolved in CH2Cb, filtered (Nylon, 0.2 ~M) and 
subjected to preparative HPLC purification (Si02, 3% MeOH-CHCl3). Fractions 
containing the compound eluting in the major peak (-11.4-12.4 min) were 
pooled and the solvent was removed in vacuo to afford 12 (63 mg, 40%) as a 
white solid. 1 H NMR data were in accord with those previously reported. 58 
MGO VII-109. 
Ethyl (S)-2-[1-[[(S)-2-tert-Butyloxycarbonyl)amino]-2-carbamoylethyl]-
amino]-2- [((4S, SR)-4- methyl- 5- phenyl- 2- oxazolidinyl)carbonyl]ethyl]-6-
amino-5-methylpyrimidine-4-carboxylate (13).58 A solution of 12 (68.7 mg, 
0.10 mmol) in degassed, freshly distilled benzene (2 mL) under an Ar 
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atmosphere was subjected to a steady stream of Ar for -10 min. The solution 
was treated with Bu3SnH (81 J...LL, 0.30 mmol) and AIBN (-3 mg, 0.02 mmol) at 
room temperature and warmed at 80 °C for 1 h. More Bu3SnH (50 J...LL, 0.19 
mmol) was added and the reaction mixture was heated for 1 h . The reaction 
mixture was concentrated in vacuo and the residue was purified by flash 
column chromatography (2% MeOH-CH2Ci2) to afford 13 (64 mg, quantita-
tive) as a white solid. 1H NMR data were in accord with those previously 
reported.58 MGO VII-146. 
NO.-(tert-ButoxycarbonyD-Nf3-[l-amino-3-(S)-(4-amino-6-ethoxycarbonyl-
5-methylpyrimidin-2-yl) propion-3-yl]-(S)-~-aminoalanine Amide (14).58 
Solid 13 (64 mg, 0.10 mmol) was treated with an ethanolic solution of NH3 
(16%, 16 mL) and the solution was stirred at 0 °C for 1.5 h. The solvent was 
removed in vacuo and the residue was purified by flash column 
chromatography (0% --> 20% MeOH-CH2Cb gradient) to afford 14 (34 mg, 
76%) as a white solid. 1H NMR data were in accord with those previously 
reported.58 MGO VII-149. 
Na.- (tert-Butoxycarbonyl)- N~-[1-amino- 3-(S)- (4-amino-6-carboxy--5-
methylpyrimidin-2-yl) propion-3-yl]-(S)-~-aminoalanine Amide (Boc-
pyrmidoblamic acid) (15). 58 A solution of 14 (34 mg, 0.076 mmol) in THF-
MeOH-H20 (3:1:1, 0.83 mL) at 0 °C was treated with aqueous 1N LiOH (0.11 
mL, 0.11 mmol) and the mixture was stirred for 1.5 h . The organic solvent 
was removed in vacuo and the aqueous phase was acidified by the addition of 
1 N HCI (0.13 mL). The solvent was removed in vacuo and the residue was 
purified by flash column chromatography (Reverse Phase-18 gel, 0% --> 50% 
MeOH-H20) to afford 15 (26 mg, 80%) as a white solid. 1 H and 13C NMR 
data were in accord with those previously reported.58 The 13C NMR 
spectrum was recorded by Dr. Ken Turnbull. MGO VII-150. 
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N-P-[1-amino-3(5 )-( 4-amino-( 6-amido-erythro-J3-h yxdroxy-L-his tid ine 
methyl ester)-5-methylpyrimidin-2-y0-propion-3-yl]-(S)-J3-aminoalanine 
Amide (20) Compound 17 was prepared by Dr. Ken Turnbull as previously 
reported by Boger et al.58 17 (2.1 mg, 2.5 J.lmol) p-cresol (1 drop), and p-
thiocresol (1 drop) were added to a Teflon tube equipped with a Teflon-coated 
magnetic stir bar. The reaction vessel was evacuated, cooled to -78 °C, and 
charged with HF (-2.0 mL). The mixture was allowed to stir at 0 °C (lh). HF 
was removed in vacuo and the resulting yellow residue was taken up in H20 
(0.5 mL). The aqueous portion was extracted with CHCl3 (1 x 0.5 mL) and the 
organic portion was washed with H 20 (1 x 0.5 mL). The combined aqueous 
portions were concentrated in vacuo to afford an off-white foam. TLC 
(analytical RP-18, 5 x 10 em, 0.25 mm thickness, 25% CH3CN /H20, MeOH 
extraction) afforded a white powder which was dissolved in H20 (1 mL) and 
filtered (0.2 J.lm) to remove particulate contaminants. Concentration in vacuo 
afforded 4 (1.2 mg, quantitative) as a white foam. The compound was 
characterized by Dr. Ken Turnbull. [a.]25 = +12.2 (c 0.03, CH30H); 1H NMR (300 
MHz, D20) 8 8.73 (s, 1H), 7.50 (s, 1H), 5.44 (d, ] = 5.7 Hz, 1H), 5.12 (d,] = 5.7 Hz, 
1H), 4 .51 (m, 1H), 4.41 (m, 1H), 3.78 (s, 3H), 3.18 (m, 2H), 3.04 (m, 1H), 2.84 (m, 
1H), 2.09 (s, 3H); IR (neat) 3384, 1736, 1664, 1460, 1380, 850, 698; FABHRMS 
(SGly), m/e 493.2272 (MH+, C19H29N1006 requires 493.2267). 
Protein Syntheses. Hin(139-190) was synthesized by automated stepwise 
solid phase chemical synthesis on an ABI 430A peptide synthesizer as 
previously reported.47-49,55 An approximately 50-mg sample of resin bound 
peptide (ca. 100 J.lmol/ g, total peptide ca. 5 J.lmol) was placed in a 12 x 80 mm 
reaction vessel. The terminal Boc protecting group was removed and the 
resin neutralized by standard procedures. 18 was prepared by Dr. Ken 
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Turnbull as previously described.58 18 (16.0 mg, 20 J.lmol) and HOBt (5.5 mg, 
42 J.lmol) were dissolved in DMF (1 mL) and DCC (4.6 mg, 22 J.lmol) was 
added. The solution was allowed to stir at room temperature for 30 min and 
added to the peptide/resin along with additional DMF (1 mL). Ninhydrin 
analysis91 indicated 88% reaction with no further improvement in yield after 
5 h . The resulting protected PBA-~-OH-His-Hin(139-190) was deprotected by 
anhydrous HF and purified by preparative reverse-phase HPLC as previously 
described.47-49,55 Laser desorption time-of-flight mass spectrometry (a-
cyano-4-hydroxy-cinnamic acid matrix, 70% acetonitrile, 2% TFA in H20) is 
consistent with the desired structure (calculated mass, 6495.5, observed, 
6493.3). A second, much smaller peak, due to Hin(139-190) (calculated mass, 
6036.1, observed, 6035.6) was also present. Hin(139-190) and EDTA-GABA-
Hin(139-190) were also synthesized, deprotected and purified according to 
previously reported procedures.47-49,55 
Fe • PBA-~-OH-His-Hin(139-190) and Fe • EDTA-Hin(139-190) were 
generated immediately prior to use by equilibration of 250 J.!M protein with 
an equal volume of 250 J.!M ferrous ammonium sulfate (FAS) for 15 min 
before dilution to the appropriate concentrations. Bleomycin was not 
incubated with FAS at high concentrations but diluted immediately after the 
addition of iron. Ni-GGH-Hin was generated in a similar fashion by 
incubation with Ni(OAch. Fe•21, its corresponding free acid complex, and 
Fe•EDTA were all incubated with FAS at ~1 mM concentrations before 
dilution. 
DNA Manipulations. The 450 bp Xba 1-Eco RI restriction fragment of the 
plasmid pMFB3644 were isolated and labeled at the 5' or 3' ends by standard 
procedures.92 A-specific93 and Maxam-Gilbert G-specific94 sequencing 
reactions were performed according to established protocols. The 450 bp Xba I-
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Eco RI restriction fragment of the plasmid pMFB36 was used for all assays 
except end-product analysis. All footprinting and affinity cleaving reactions 
were performed at room temperature. 
DNase I footprinting95 reaction conditions were 20 mM phosphate, 20 
mM NaCl, 10 mM MgCl2, 100 ~M OTT, 0.004 units DNase I, 100 ~M calf 
thymus DNA, and -20,000 cpm labeled DNA, pH 7.5. The DNA binding 
molecules were allowed to equilibrate with the DNA for 15 min. Reactions 
were then initiated by the addition of a stock solution of DNase I, MgCl2, and 
OTT and allowed to proceed 10 min at room temperature. Reactions were 
quenched by the addition of a 3 M ammonium acetate solution containing 
250 mM EDT A followed by ethanol precipitation. 
Fe•PBA-~-OH-His-Hin(139-190) and Fe•EDTA-Hin(139-190) affinity 
cleaving reaction conditions were 20 mM phosphate, 20 mM NaCl, 5 mM 
OTT, 100 ~M calf thymus DNA, -10,000 cpm labeled DNA, and 5 ~M 
Fe•EDTA-Hin(139-190) or 10 ~M Fe•PBA-~-OH-His-Hin(139-190), pH 7.5. 
Ni•GGH-Hin(139-190) affinity cleavage reaction conditions were 20 mM 
phosphate, 20 mM NaCl, 5 ~M monoperoxyphthalic acid, 100 ~M calf 
thymus DNA, -10,000 cpm labeled DNA, and 5 ~M Ni•GGH-Hin, pH 7.5. 
Fe•Bleomycin affinity cleavage reaction conditions were 20 mM phosphate, 
20 mM NaCl, 5 mM DTT, 100 ~M calf thymus DNA, -10,000 cpm labeled 
DNA, and 2.5 ~M Fe• Bleomycin, pH 7.5. All affinity cleaving reagents were 
allowed to equilibrate with the DNA for 15 min before reactions were 
initiated with the addition of DTT or monoperoxyphthalic acid. Fe•EDTA-
Hin(139-190) and Ni•GGH-Hin reactions were allowed to proceed for 1 h, 
Fe•PBA-~-OH-His-Hin(139-190) reactions for 6 h, and Fe•Bleomycin reactions 
for 15 min before they were terminated by ethanol precipitation. Residues 
were dried and resuspended in 100 mM tris-borate-EDTA/80% formamide 
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loading buffer. Reaction products were analyzed by electrophoresis on 6% 
polyacrylamide denaturing gels (5% crosslink, 7M urea) . After 
electrophoresis, gels were dried and autoradiographed. Gels were analyzed 
using storage phosphor technology. Storage phosphor screens were pressed 
against dried gels and exposed. A Molecular Dynamics 4005 Phosphorlmager 
was used to obtain data from storage screens, and data were analyzed by 
performing volume integrations using the ImageQuant v.3.0 software 
running on an AST Premium 386/33 computer. 
End Product Analysis. For 3'-end product analysis, reactions were 
performed on the 562 bp 5' end-labeled Hind III/ Rsa I restriction fragment 
from pDPM3454 containing the Hin binding site secondary. Fe•PBA-~-OH­
His-Hin(139-190) and Fe•4 affinity cleaving reaction conditions were 20 mM 
phosphate, 20 mM NaCl, 5 mM OTT, 100 ~M calf thymus DNA, and 100 ~M 
Fe•4 or 10 ~M Fe•PBA-~-OH-His-Hin(139-190), pH 7.5. Fe• Bleomycin affinity 
cleavage reaction conditions were 20 mM phosphate, 20 mM NaCl, 5 mM 
OTT, 100 ~M calf thymus DNA, and 2.5 ~M Fe•Bleomycin, pH 7.5. MPE•Fe 
reaction conditions were 20 mM phosphate, 20 mM NaCl, 5 mM OTT, 5 ~M 
MPE•Fe. Cleaving agents were allowed to equilibrate with the DNA for 15 
min before reactions were initiated by the addition of OTT. MPE•Fe and 
Fe•Bleomycin reactions were allowed to proceed 15 min and Fe•PBA-~-OH­
His-Hin(139-190) and Fe•4 reactions for 4 h at room temperature before 
termination by lyophilization. Where base treatment was appropriate, 
residues were resuspended in 50 ~L of 0.1 N butylamine and heated at 90 oc 
for 30 min. Reaction solutions were frozen and lyophilized. 
The presence of 3'-phosphate groups was tested using T4 polynucleotide 
kinase to remove the 3'-phosphate groups?3 After the DNA reactions and 
base treatment, DNA residues were resuspended in 25 ~L water, heated to 90 
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oc for 5 min, and cooled on ice. 25 ~L of a buffer containing 20 mM Tris-HCl, 
pH 6.6, 20 mM MgCl2, and 10 mM ~-mercaptoethanol were added followed by 
2 ~L T4 polynucleotide kinase (10 units/mL). Reactions were incubated 1 h at 
37 °C and terminated by ethanol precipitation. Residues were prepared for gel 
electrophoresis (20% acrylamide, 5% crosslink, 7M urea) as described above. 
Storage phosphor screens were pressed against the gels and exposed. Gels 
were analyzed as described above. 
For 5'-end product analysis, reactions were performed on the 562 bp 5' 
end-labeled Eco RI/ Rsa I restriction fragment from pDPM34. Reaction 
conditions were the same as above, except 5 ~M Fe • Bleomycin was used. 
Incubation time before reaction initiation with DTT was 15 min in all cases. 
MPE•Fe and Fe•Bleomycin reactions were allowed to proceed 20 min and 
Fe • PBA- ~-OH-His-Hin(139-190) and Fe • 4 reactions for 4 h at room 
temperature before quenching by phenol (2 x 2:1 phenol:chloroform, equal 
volume) extraction and ethanol precipitation. The presence of 5'-phosphate 
groups was tested using calf alkaline phosphatase to remove the 5'-phosphate 
groups. The residues were resuspended in H20 (45 ~L) and heat denatured at 
90 °C for 5 min. lOx dephosphorylation buffer (Boehringer-Mannheim, 7 J..LL) 
was added, followed by 20 ~L of enzyme (Boehringer Mannheim, 1 unit/~L). 
The reaction mixture was incubated at 37 °C for 1 h and ethanol precipitated. 
Quantitative Footprint Titrations. The above reaction conditions were 
modified for quantitative footprinting as follows. Stock solutions of Hin(139-
190), PBA-~-OH-His-Hin(139-190), or Fe•PBA-~-OH-His-Hin(139-190) were 
diluted serially to give 15 solutions of concentrations ranging from 50 nM to 
150 ~M, leading to final reaction concentrations of 10 nM to 30 ~M. Final 
reaction conditions were 20 mM bis-Tris•HCl, 20 mM NaCl, 5 mM DTT, 100 
J..LM bp calf thymus DNA , 0.004 units DNase I, and 15,000 cpm 5'-32p end-
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labeled DNA, pH 7.6. The proteins were allowed to equilibrate with the DNA 
for 1 h before the reactions were initiated by the addition of a stock solution 
of DNase I, MgCl2, and DTT and allowed to proceed 10 min at room 
temperature. Reactions were quenched by the addition of a 3 M ammonium 
acetate solution containing 250 mM EDTA. Reaction mixtures were diluted 
2.5 fold and extracted with an equal volume of phenol and then butanol 
before addition of 5 IJ.L 20 mg/mL glycogen and ethanol precipitation. 
Residues were prepared for gel electrophoresis as described above. 
Footprint Titration Fitting Procedure. The footprint titration gels were 
quantitated using storage phosphor technology, and data were analyzed by 
performing volume integrations of the target and reference sites using the 
ImageQuant v.3.0 software running on an AST Premium 386/33 computer. 
The target sites chosen were the five Hin half sites found in the 450 bp Xba I-
Eco RI restriction fragment of the plasmid pMFB36. Specifically, bands at the 
following sequences were quantitated, moving from left to right in the 
sequence (Fig. 5): hixL IRL, 5'-TTCTT-3' (upper strand); hixL IRR, 5'-
TATCAA-3' (lower strand); tertiary, 5'-TCTCATGGA-3' (lower strand); 
secondary IRL 5'-TTCCTT-3' (upper strand); and secondary IRR, 5'-TTCTCC-3' 
(lower strand). A reference site between the tertiary and secondary sites of 5'-
ACTAA-3' was also quantitated. 
The data from the DNase I footprint titrations were analyzed as 
previously described?2 The apparent DNA target site saturation, Bapp, was 
calculated using the following equation: 
(1) 
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where ltot and Iref are the integrated volumes of the target and reference sites, 
respectively, and ltot0 and Iret correspond to those values for a DNase I 
control lane to which no protein has been added. At higher concentrations of 
protein (> 10 IJ.M), the reference sites become partially protected, resulting in 
low Oapp values. For these data points, Iref values were corrected by 
multiplying the amount of radioactivity loaded per lane (CPMt0 t) by the 
mean ratio of Iref /CPMtot for all data points from lanes with <10 IJ.M protein. 
The ([Llt0 t, Oapp) data points were fit to a Langmuir binding isotherm by 
minimizing the difference between Oapp and Ont: 
Ka n[L]totn 
1 + Ka n[L]tot n 
(2) 
where [Lltot corresponds to the total protein concentration, Ka corresponds to 
the apparent monomeric association constant, and Omin and Omax represent 
the experimentally determined site saturation values when the site is 
unoccupied or saturated, respectively. 
Data were fit using a nonlinear least-squares fitting procedure of 
KaleidaGraph software (version 3.1, Abelbeck software) running on a 
Macintosh Ilfx computer with Ka, Omax, Omin and n as the adjustable 
parameters. All lanes from each gel were used unless visual inspection of 
the computer image from a storage phosphor screen revealed a flaw at the 
target or reference site, or the Oapp value was greater than two standard errors 
away from values in both neighboring lanes, using a standard error in Oapp 
of 0.1. The goodness-of-fit of the binding curves was evaluated by the 
correlation coefficient, with R> 0.97 as the criterion for an acceptable fit. Three 
or four sets of acceptable data were obtained for all sites except for secondary 
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IRR, for which no data are reported. Data were normalized using the 
following equation: 
0app- 0min 
0max- 0min (3) 
The association constants were calculated by fitting the average Onorm values from 
three or four gels to eq. 2 as described above. The standard deviation of 
calculated association constants from each gel is also given (Table 1). The Hill 
coefficient, n, varied between the sites hixL and secondary. Values ranged from 
1.5 to 1.9 for the three proteins at the two hixL half sites. At secondary IRL, n 
was -1.0 for Fe(II)•PBA-!)-OH-His-Hin(139-190) and PBA-!)-OH-His-Hin(139-190) 
and -1.5 for Hin(139-190). The standard deviations for n were 0.1-0.3. 
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